_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
718227313,5/10/2015 11:33:37,1633613900,5/10/2015 11:31:54,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"Fetal/Neonatal Morbidity Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",N/A,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 11:35:30,1633614316,5/10/2015 11:33:51,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],received,n/a,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 11:42:19,1633615784,5/10/2015 11:41:25,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,[MANIFESTATION],[MANIFESTATION],during the,n/a,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 11:50:30,1633617682,5/10/2015 11:49:40,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggest increased risk in infants of mothers who received anxiolytics,n/a,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:02:37,1633620307,5/10/2015 12:01:32,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[CONTRAINDICATES] [OTHER],"[CONTRAINDICATES]
[OTHER]",during,N/A,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:09:12,1633621639,5/10/2015 12:07:55,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],congenital malformations,none,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:14:28,1633622648,5/10/2015 12:13:52,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],during the,HAPPENS DURING THE PREGENCY,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:24:46,1633625125,5/10/2015 12:23:23,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES] [SIDE_EFFECT] [ASSOCIATED_WITH] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]
[SIDE_EFFECT]",increased risk during,N/A,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:33:56,1633627169,5/10/2015 12:32:52,false,prodege,1,27934334,GBR,C7,Coventry,109.150.225.5,[CONTRAINDICATES],[CONTRAINDICATES],increased risk of congenital malformations,N/A,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:35:29,1633627470,5/10/2015 12:34:33,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[NONE],[NONE],N/A,No relation between the two,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:59:19,1633633511,5/10/2015 12:57:58,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],malformations,Side effect,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 12:59:57,1633633738,5/10/2015 12:58:26,false,clixsense,1,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],mothers who received,n/a,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 13:03:47,1633634712,5/10/2015 13:03:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],suggest increased risk,n/a,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 13:05:57,1633635274,5/10/2015 13:05:13,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],increased risk,n/a,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227313,5/10/2015 13:22:31,1633639483,5/10/2015 13:21:15,false,clixsense,1,6362702,GBR,B7,Bristol,90.222.102.171,[CAUSES],[CAUSES],increased risk congenital malformations,N/A,207,184,-1,234,195,TWrex-cause,803080-FS1,"b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE during the FIRST TRIMESTER OF PREGNANCY",FIRST TRIMESTER OF PREGNANCY,MEPROBAMATE
718227314,5/10/2015 11:24:32,1633611785,5/10/2015 11:23:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight,",N/A,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:30:31,1633613069,5/10/2015 11:30:12,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],were treated,n/a,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:35:01,1633614166,5/10/2015 11:33:46,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],TYPE 2 DIABETES MELLITUS who were treated with metformin,n/a,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:43:57,1633616123,5/10/2015 11:43:19,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[SIDE_EFFECT],[SIDE_EFFECT],metformin,5252,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:45:46,1633616524,5/10/2015 11:45:20,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treated with,n/a,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:46:46,1633616726,5/10/2015 11:45:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,DIABETES MELLITUS can be treated with  METFORMIN,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:47:18,1633616818,5/10/2015 11:46:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treated with,N/A,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 11:50:50,1633617775,5/10/2015 11:50:30,false,prodege,1.0,22031444,GBR,M4,Southampton,78.146.6.207,[TREATS],[TREATS],treated,N/a,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 12:11:34,1633622122,5/10/2015 12:10:55,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],METFORMIN,TREATMENTS,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 12:18:55,1633623654,5/10/2015 12:18:32,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treated with,N/A,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 12:28:38,1633626069,5/10/2015 12:27:58,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[TREATS],[TREATS],treated,N/A,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 12:32:12,1633626800,5/10/2015 12:31:25,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[OTHER],[OTHER],treated,T2 Diabetes is treated with metformin,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 12:51:51,1633631637,5/10/2015 12:50:43,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],treated with,n/a,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 12:54:42,1633632325,5/10/2015 12:53:54,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treated,Treatment for,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227314,5/10/2015 13:01:05,1633634022,5/10/2015 13:00:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treated with,n/a,0,220,-1,23,229,TWrex-cause,803480-FS1,"TYPE 2 DIABETES MELLITUS who were treated with bedtime insulin plus metformin did not gain weight, had fewer hypoglycemic episodes, and had better glycemic control than those treated with bedtime insulin plus glyburide, METFORMIN and glyburide, or morning insulin.",TYPE 2 DIABETES MELLITUS,METFORMIN
718227315,5/10/2015 14:56:52,1633664103,5/10/2015 14:56:33,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SIDE_EFFECT],[SIDE_EFFECT],who develop while receiving the drug.,n/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 15:11:31,1633667895,5/10/2015 15:10:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],discontinue INTERFERON ALFA THERAPY in patients who develop AUTOIMMUNE DISEASE,n/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 15:17:19,1633669198,5/10/2015 15:16:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],THERAPY,N/A,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 15:23:57,1633671218,5/10/2015 15:23:29,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],discontinue,N/A,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 15:25:30,1633671610,5/10/2015 15:24:24,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],INTERFERON ALFA THERAPY who develop AUTOIMMUNE DISEASE while receiving drug.,N/A,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:15:14,1633684405,5/10/2015 16:14:46,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CONTRAINDICATES],[CONTRAINDICATES],discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE,N/A,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:17:04,1633684957,5/10/2015 16:16:22,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[SIDE_EFFECT],[SIDE_EFFECT],while receiving the drug.,n/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:17:52,1633685178,5/10/2015 16:17:06,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],discontinue INTERFERON ALFA THERAPY patients who develop AUTOIMMUNE DISEASE,N/A,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:20:07,1633685708,5/10/2015 16:19:36,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[CAUSES],[CAUSES],develop while receiving the drug.,n/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:24:31,1633686817,5/10/2015 16:23:24,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[MANIFESTATION],[MANIFESTATION],develop an,N/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:40:56,1633691386,5/10/2015 16:40:08,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],"Closely monitor, or discontinue",there is a relation,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 16:49:36,1633694048,5/10/2015 16:48:56,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[SIDE_EFFECT],[SIDE_EFFECT],develop,N/A,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 17:03:00,1633697638,5/10/2015 17:02:42,false,instagc,1.0,23035364,USA,"","",73.29.106.28,[TREATS],[TREATS],patients,n/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 17:09:35,1633699546,5/10/2015 17:08:18,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",who develop while receiving the drug.,n/a,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227315,5/10/2015 17:28:38,1633705692,5/10/2015 17:28:10,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",who develop an,I didn´t select none.,86,35,-1,103,58,TWrex-cause,803085-FS1,"b  Closely monitor, or discontinue INTERFERON ALFA THERAPY in patients who develop an AUTOIMMUNE DISEASE while receiving the drug.",AUTOIMMUNE DISEASE,INTERFERON ALFA THERAPY
718227316,5/10/2015 11:40:58,1633615579,5/10/2015 11:40:41,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TEST,n/a,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 11:50:36,1633617718,5/10/2015 11:49:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME,N/A,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 11:53:42,1633618380,5/10/2015 11:53:09,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],in the diagnosis of,n.a,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 12:04:55,1633620784,5/10/2015 12:04:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,n/a,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 12:16:04,1633623004,5/10/2015 12:15:02,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,N/A,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 12:24:50,1633625129,5/10/2015 12:24:14,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],and,TREATS,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 12:26:30,1633625482,5/10/2015 12:25:47,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,none,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 12:36:55,1633627733,5/10/2015 12:36:18,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,N/A,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 12:52:58,1633631924,5/10/2015 12:52:44,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,N/A,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 13:08:41,1633636040,5/10/2015 13:08:22,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,n/a,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 13:09:13,1633636204,5/10/2015 13:08:41,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,Diagnosed by,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 13:20:07,1633638861,5/10/2015 13:19:41,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis of,n/a,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 13:34:37,1633642704,5/10/2015 13:33:58,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[LOCATION],[LOCATION],Jayasena,gnbgbn,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 13:37:17,1633643395,5/10/2015 13:35:30,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis CUSHING'S SYNDROME,N/A,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227316,5/10/2015 13:39:38,1633643924,5/10/2015 13:38:51,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],LOW DOSE DEXAMETHASONE SUPPRESSION TEST in diagnosis of CUSHING'S SYNDROME,N/A,227,167,-1,244,206,TWrex-cause,803000-FS1,"2]  Martin NM, Dhillo WS, Banerjee A, Abdulali A, Jayasena CN, Donaldson M, et al. Comparison of the dexamethasone suppressed corticotropin releasing hormone test and LOW DOSE DEXAMETHASONE SUPPRESSION TEST in the diagnosis of CUSHING'S SYNDROME",CUSHING'S SYNDROME,LOW DOSE DEXAMETHASONE SUPPRESSION TEST
718227317,5/10/2015 13:11:11,1633636760,5/10/2015 13:10:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Prolonged therapy,n/a,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:25:54,1633640285,5/10/2015 13:24:19,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy of,n/a,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:38:14,1633643588,5/10/2015 13:38:01,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[PREVENTS],[PREVENTS],analysis,sdsc,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:42:34,1633644695,5/10/2015 13:41:49,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CHRONIC HEPATITIS C with PEGINTERFERON,N/a,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:42:58,1633644789,5/10/2015 13:41:38,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[TREATS],[TREATS],low dose,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:43:19,1633644838,5/10/2015 13:42:10,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:43:24,1633644850,5/10/2015 13:43:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],with low,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:44:19,1633645121,5/10/2015 13:43:04,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],therapy,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:46:12,1633645610,5/10/2015 13:44:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Effectiveness,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 13:48:50,1633646305,5/10/2015 13:48:14,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],therapy,n/a,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 14:13:18,1633652599,5/10/2015 14:11:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy with,low dosed used to treat,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 14:20:55,1633654614,5/10/2015 14:19:23,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HEPATITIS,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 14:24:36,1633655543,5/10/2015 14:24:20,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 14:36:18,1633658611,5/10/2015 14:35:27,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],with,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227317,5/10/2015 14:36:31,1633658676,5/10/2015 14:35:44,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[TREATS],[TREATS],therapy with,N/A,377,411,-1,395,424,TWrex-cause,804694-FS1,"cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol dependent patients with liver cirrhosis: randomised, double blind controlled study  Non peptide arginine vasopressin antagonists: the vaptans  New England Journal of Medicine  Prolonged therapy of advanced CHRONIC HEPATITIS C with low dose PEGINTERFERON",CHRONIC HEPATITIS C,PEGINTERFERON
718227318,5/10/2015 11:30:05,1633612923,5/10/2015 11:28:15,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.,N/A,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 11:33:15,1633613839,5/10/2015 11:32:38,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 11:40:28,1633615453,5/10/2015 11:38:28,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],ZIDOVUDINE therapy,n/a,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 11:48:46,1633617236,5/10/2015 11:48:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy,n/a,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:00:04,1633619688,5/10/2015 11:59:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],therapy,N/A,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:06:04,1633620977,5/10/2015 12:04:23,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,ADVANCED AIDS RELATED COMPLEX  and it's relation to ZIDOVUDINE were not discussed.,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:13:32,1633622509,5/10/2015 12:13:01,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],therapy in patients,TREATS THE PATIENTS,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:21:42,1633624353,5/10/2015 12:21:13,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],therapy,N/A,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:32:05,1633626766,5/10/2015 12:31:35,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[TREATS],[TREATS],therapy,N/A,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:34:06,1633627189,5/10/2015 12:33:37,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],therapy,N/A,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:57:04,1633632961,5/10/2015 12:56:12,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],therapy,n/a,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 12:57:26,1633633065,5/10/2015 12:56:51,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[NONE],[NONE],N/a,The is no relation,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 13:02:44,1633634528,5/10/2015 13:02:20,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Prolonged therapy,n/a,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 13:04:06,1633634785,5/10/2015 13:02:25,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],therapy,n/a,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227318,5/10/2015 13:20:05,1633638834,5/10/2015 13:18:44,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ZIDOVUDINE AIDS RELATED,N/A,95,50,-1,123,60,TWrex-cause,800374-FS1,"Fischl MA, Richman DD, Causey DM et al. Prolonged ZIDOVUDINE therapy in patients with AIDS and ADVANCED AIDS RELATED COMPLEX.",ADVANCED AIDS RELATED COMPLEX,ZIDOVUDINE
718227319,5/10/2015 13:11:41,1633636886,5/10/2015 13:11:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],develops after,n/a,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:39:02,1633643770,5/10/2015 13:38:49,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[PREVENTS],[PREVENTS],clearly,nn,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:43:53,1633645001,5/10/2015 13:43:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],ASBESTOSIS develops after exposure to ASBESTOS FIBERS,N/a,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:44:27,1633645184,5/10/2015 13:43:48,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],ASBESTOSIS ASBESTOS FIBERS,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:44:27,1633645185,5/10/2015 13:43:43,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[ASSOCIATED_WITH],[ASSOCIATED_WITH],develops significant exposure,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:47:59,1633646072,5/10/2015 13:47:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",develops after,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:48:32,1633646221,5/10/2015 13:47:08,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[MANIFESTATION],[MANIFESTATION],develops,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 13:52:48,1633647345,5/10/2015 13:52:23,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],heavy exposure,n/a,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:16:21,1633653374,5/10/2015 14:14:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],develops after exposure,causes it,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:23:04,1633655170,5/10/2015 14:22:06,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],ASBESTOS FIBERS,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:25:15,1633655833,5/10/2015 14:24:59,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[CAUSES] [SYMPTOM] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:37:25,1633658962,5/10/2015 14:37:03,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],develops after,n/a,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:38:08,1633659232,5/10/2015 14:37:25,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[CAUSES],[CAUSES],develops after significant exposure,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:38:36,1633659289,5/10/2015 14:36:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[MANIFESTATION],[MANIFESTATION],develops,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227319,5/10/2015 14:46:09,1633661288,5/10/2015 14:44:32,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],ASBESTOSIS develops after significant heavy exposure to ASBESTOS FIBERS,N/A,56,116,1,65,131,TWrex-cause,811665-FS1,Rationale: • Epidemiologic studies clearly suggest that ASBESTOSIS develops after significant and heavy exposure to ASBESTOS FIBERS,ASBESTOSIS,ASBESTOS FIBERS
718227320,5/10/2015 11:38:55,1633615118,5/10/2015 11:38:26,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],are found in,n/a,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 11:45:37,1633616492,5/10/2015 11:44:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"SYN: aphthous stomatitis canker sore ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",N/A,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 11:50:45,1633617760,5/10/2015 11:50:03,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[MANIFESTATION],[MANIFESTATION],are found in,n/a,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 12:03:11,1633620411,5/10/2015 12:02:43,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are found in,n/a,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 12:13:16,1633622464,5/10/2015 12:12:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],are found in,N/A,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 12:22:08,1633624490,5/10/2015 12:21:12,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[PREVENTS],[PREVENTS],"found in stomatitis,",SYMPTOMS,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 12:22:37,1633624572,5/10/2015 12:21:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],are found,none,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 12:34:57,1633627406,5/10/2015 12:34:15,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",are found in,N/A,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 12:51:08,1633631518,5/10/2015 12:50:39,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],are found in,N/A,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 13:07:22,1633635720,5/10/2015 13:06:50,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],found,Symptom,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 13:07:32,1633635752,5/10/2015 13:07:02,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are found in,n/a,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 13:17:27,1633638209,5/10/2015 13:16:59,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],are found in,n/a,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 13:32:08,1633641941,5/10/2015 13:31:03,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and some cancers.,N/A,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 13:32:25,1633642048,5/10/2015 13:31:33,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE",N/A,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227320,5/10/2015 13:32:51,1633642226,5/10/2015 13:32:34,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[CAUSES],[CAUSES],ETIOLOGY:,gfg,53,113,1,67,128,TWrex-cause,814934-FS1,"SYN:   aphthous stomatitis ;  canker sore  ETIOLOGY: APHTHOUS ULCERS are found in stomatitis, Beh et's syndrome, CROHN'S DISEASE acquired immunodeficiency syndrome (AIDS), and some cancers.",APHTHOUS ULCERS,CROHN'S DISEASE
718227321,5/10/2015 11:40:40,1633615531,5/10/2015 11:40:19,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],Treatment,n/a,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 11:49:40,1633617480,5/10/2015 11:48:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",N/A,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 11:53:08,1633618294,5/10/2015 11:52:50,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Treatment of,n/a,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 12:04:34,1633620679,5/10/2015 12:04:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment of,n/a,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 12:14:57,1633622774,5/10/2015 12:14:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Treatment of,N/A,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 12:24:13,1633624992,5/10/2015 12:23:54,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],"with prednisone,",TREATS IS IN THE SENTENCE,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 12:25:45,1633625321,5/10/2015 12:24:35,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],Treatment,HYPEREOSINOPHILIC SYNDROMES treated with   HYDROXYUREA,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 12:36:17,1633627652,5/10/2015 12:36:01,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],Treatment of,N/A,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 12:52:42,1633631866,5/10/2015 12:52:28,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",Treatment of,treated by,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 13:08:22,1633635955,5/10/2015 13:08:05,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment of,n/a,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 13:08:40,1633636016,5/10/2015 13:08:15,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],Treatment,Treated by,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 13:19:40,1633638735,5/10/2015 13:18:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],Treatment with,n/a,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 13:33:52,1633642442,5/10/2015 13:33:39,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[CAUSES],[CAUSES],"prednisone,",dssc,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 13:35:29,1633642878,5/10/2015 13:34:18,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[TREATS],[TREATS],Treatment HYPEREOSINOPHILIC SYNDROMES HYDROXYUREA interferon.,N/A,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227321,5/10/2015 13:36:21,1633643103,5/10/2015 13:35:28,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[TREATS],[TREATS],Treatment of HYPEREOSINOPHILIC SYNDROMES with HYDROXYUREA,N/A,13,58,-1,39,69,TWrex-cause,800416-FS1,"Treatment of HYPEREOSINOPHILIC SYNDROMES with prednisone, HYDROXYUREA and interferon.",HYPEREOSINOPHILIC SYNDROMES,HYDROXYUREA
718227322,5/10/2015 11:40:18,1633615417,5/10/2015 11:40:00,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],Treatment,n/a,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 11:48:32,1633617205,5/10/2015 11:47:11,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[IS_A],[IS_A],Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.,N/A,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 11:52:48,1633618245,5/10/2015 11:52:17,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],Treatment of,n/a,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 12:04:14,1633620619,5/10/2015 12:03:36,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],Treatment of,n/a,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 12:14:27,1633622650,5/10/2015 12:13:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],Treatment of,N/A,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 12:23:52,1633624932,5/10/2015 12:22:48,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],Treatment of,TREATMENT OF IS IN THE SENTENCE,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 12:24:35,1633625083,5/10/2015 12:23:50,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Treatment,none,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 12:35:59,1633627603,5/10/2015 12:35:39,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],Treatment of,N/A,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 12:52:27,1633631792,5/10/2015 12:52:10,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[OTHER] [TREATS],"[TREATS]
[OTHER]",Treatment of,treated by,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 13:08:04,1633635887,5/10/2015 13:07:50,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Treatment of,n/a,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 13:08:13,1633635917,5/10/2015 13:07:50,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],Treatment,Treated by,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 13:18:11,1633638341,5/10/2015 13:17:49,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],Treatment with METHYLDOPA,n/a,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 13:33:31,1633642392,5/10/2015 13:33:17,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SEVERE,dfdsvf,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 13:33:51,1633642446,5/10/2015 13:32:56,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[TREATS],[TREATS],Treatment of SEVERE HYPERTENSION compared with METHYLDOPA,N/A,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227322,5/10/2015 13:34:17,1633642605,5/10/2015 13:33:30,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[TREATS],[TREATS],Treatment SEVERE HYPERTENSION METHYLDOPA,N/A,49,98,-1,67,108,TWrex-cause,800261-FS1,"Wallin JD, Wilson D, Winer N et al. Treatment of SEVERE HYPERTENSION with labetalol compared with METHYLDOPA and furosemide.",SEVERE HYPERTENSION,METHYLDOPA
718227323,5/10/2015 11:22:04,1633611267,5/10/2015 11:21:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],Active against certain CESTODES,N/A,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:29:27,1633612811,5/10/2015 11:28:22,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],pathogenic to humans,n/a,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:32:57,1633613791,5/10/2015 11:31:58,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[IS_A],[IS_A],CESTODES (tapeworms) (DOG AND CAT TAPEWORM,n/a,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:42:33,1633615849,5/10/2015 11:41:33,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Active against,none,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:42:41,1633615879,5/10/2015 11:42:23,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[CONTRAINDICATES],[CONTRAINDICATES],including,525,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:45:03,1633616359,5/10/2015 11:44:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],including,n/a,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:45:13,1633616413,5/10/2015 11:43:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],including,N/A,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:49:54,1633617521,5/10/2015 11:49:19,false,prodege,1.0,22031444,GBR,M4,Southampton,78.146.6.207,[IS_A],[IS_A],(tapeworms),N/a,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 11:53:16,1633618301,5/10/2015 11:52:26,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[IS_A],[IS_A],(tapeworms) including,n/a,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 12:10:29,1633621945,5/10/2015 12:10:02,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(DOG AND CAT TAPEWORM,DOGS AND CATS ARE AFFECTED BY IT,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 12:18:10,1633623493,5/10/2015 12:17:23,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],including,N/A,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 12:27:28,1633625785,5/10/2015 12:26:24,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[IS_A],[IS_A],CESTODES (tapeworms),N/A,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 12:30:46,1633626471,5/10/2015 12:30:18,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[IS_A],[IS_A],including,N/A,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 12:50:05,1633631153,5/10/2015 12:48:30,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],certain including,n/a,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227323,5/10/2015 12:52:25,1633631777,5/10/2015 12:51:31,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PART_OF],[PART_OF],(tapeworms),Same as,32,147,1,39,168,TWrex-cause,811155-FS1,"101 •    Active against certain CESTODES (tapeworms) pathogenic to humans including  Diphyllobothrium latum  (fish tapeworm),  Dipylidium caninum  (DOG AND CAT TAPEWORM  Hymenolepis nana  (dwarf tapeworm),  Taenia saginata  (beef tapeworm), and  T. solium  (pork tapeworm.",CESTODES,(DOG AND CAT TAPEWORM
718227324,5/10/2015 11:34:55,1633614132,5/10/2015 11:33:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","PROPRANOLOL HYDROCHLORIDE audio A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",N/A,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 11:35:49,1633614423,5/10/2015 11:35:31,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treat,n/a,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 11:42:58,1633615952,5/10/2015 11:42:20,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],to treat,n/a,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 11:51:05,1633617840,5/10/2015 11:50:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],used primarily treat,n/a,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:03:15,1633620423,5/10/2015 12:02:42,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],used primarily to treat,N/A,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:10:40,1633622007,5/10/2015 12:09:13,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],treat,ANGINA PECTORIS is treated with  PROPRANOLOL HYDROCHLORIDE,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:15:18,1633622849,5/10/2015 12:14:29,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treat,TREATMENT OF HYPERTENSION,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:25:37,1633625295,5/10/2015 12:24:47,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],used to treat,N/A,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:35:21,1633627441,5/10/2015 12:33:57,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[TREATS],[TREATS],treat,N/A,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:35:52,1633627560,5/10/2015 12:35:31,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],used to treat,N/A,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 12:59:47,1633633697,5/10/2015 12:59:20,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treat,TreTed by,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 13:00:40,1633633909,5/10/2015 12:59:58,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],used primarily to treat,n/a,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 13:04:09,1633634787,5/10/2015 13:03:48,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],used to treat,n/a,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 13:06:28,1633635407,5/10/2015 13:05:58,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],used to treat,n/a,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227324,5/10/2015 13:23:44,1633639730,5/10/2015 13:22:04,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[TREATS],[TREATS],treat,None,128,0,-1,142,25,TWrex-cause,804501-FS1,"PROPRANOLOL HYDROCHLORIDE    (                  audio )  A beta adrenergic blocking agent used primarily to treat hypertension, ANGINA PECTORIS and many cardiac rhythm disturbances.",ANGINA PECTORIS,PROPRANOLOL HYDROCHLORIDE
718227325,5/10/2015 13:53:06,1633647419,5/10/2015 13:52:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:03:58,1633650059,5/10/2015 14:03:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],CUTANEOUS INVOLVEMENT URTICARIA of anaphylaxis.,N/a,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:09:37,1633651604,5/10/2015 14:08:36,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Physical Examination reported experiencing,N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:11:15,1633652027,5/10/2015 14:09:44,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],"Flushing, and angioedema",n/a,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:17:31,1633653745,5/10/2015 14:17:00,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:32:12,1633657591,5/10/2015 14:31:58,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [TREATS] [NONE],"[TREATS]
[PREVENTS]
[NONE]",no,no,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:43:40,1633660752,5/10/2015 14:42:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],have been reported,both are symptoms of  same,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:47:29,1633661571,5/10/2015 14:46:56,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],URTICARIA,N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 14:49:00,1633661937,5/10/2015 14:48:04,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],have been reported in patients,n/a,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 15:03:02,1633665531,5/10/2015 15:02:14,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CUTANEOUS INVOLVEMENT URTICARIA reported in patients,n/a,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 15:11:30,1633667879,5/10/2015 15:10:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reported,DID NOT SELECT NONE,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 15:13:38,1633668366,5/10/2015 15:10:59,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],CUTANEOUS INVOLVEMENT URTICARIA have been reported,N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 15:15:08,1633668706,5/10/2015 15:13:09,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[PART_OF],[PART_OF],88% 100% experiencing,N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 16:06:50,1633682187,5/10/2015 16:06:00,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"CUTANEOUS INVOLVEMENT Flushing, URTICARIA and angioedema",N/A,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227325,5/10/2015 16:11:45,1633683394,5/10/2015 16:10:48,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[NONE],[NONE],N/A,it is not clear that they are related,22,56,1,42,65,TWrex-cause,813610-FS1,"Physical Examination  CUTANEOUS INVOLVEMENT   Flushing, URTICARIA and angioedema have been reported in 88% to 100% of patients experiencing anaphylaxis.",CUTANEOUS INVOLVEMENT,URTICARIA
718227326,5/10/2015 13:10:50,1633636657,5/10/2015 13:10:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],does not rule out,n/a,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:24:18,1633639913,5/10/2015 13:23:44,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],"important physical finding,",n/a,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:37:54,1633643504,5/10/2015 13:37:28,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],prominent,xaxaz,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:41:37,1633644449,5/10/2015 13:40:33,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[NONE],[NONE],N/A,Nothing,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:41:48,1633644475,5/10/2015 13:41:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"MYOCLONUS physical finding, CJD",N/a,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:42:08,1633644551,5/10/2015 13:41:18,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"MYOCLONUS important physical finding, absence does rule out CJD",N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:43:03,1633644798,5/10/2015 13:42:08,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"important physical finding,",N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:43:04,1633644800,5/10/2015 13:42:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],absence,N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:44:42,1633645221,5/10/2015 13:43:50,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],"reaction,",N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 13:48:14,1633646144,5/10/2015 13:47:00,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[NONE],[NONE],n/a,does not rule out CJD,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 14:11:52,1633652200,5/10/2015 14:10:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],absence does not rule out CJD,a symptom may or may not be present,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 14:19:22,1633654194,5/10/2015 14:18:29,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],MYOCLONUS,N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 14:24:18,1633655479,5/10/2015 14:23:42,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 14:35:26,1633658394,5/10/2015 14:35:00,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],"finding,",N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227326,5/10/2015 14:35:43,1633658452,5/10/2015 14:34:33,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[SYMPTOM],[SYMPTOM],"important physical finding,",N/A,0,137,1,8,140,TWrex-cause,813336-FS1,"MYOCLONUS (a jerky reaction, particularly prominent after a startle) is an important physical finding, but its absence does not rule out CJD",MYOCLONUS,CJD
718227327,5/10/2015 11:38:09,1633614922,5/10/2015 11:37:44,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],masks the symptoms,n/a,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 11:43:15,1633615987,5/10/2015 11:41:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,N/A,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 11:49:24,1633617391,5/10/2015 11:48:51,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CONTRAINDICATES],[CONTRAINDICATES],masks the symptoms,n/a,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 11:58:28,1633619388,5/10/2015 11:57:40,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],increase the rate of acclimatization,n/a,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 12:11:31,1633622114,5/10/2015 12:09:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [OTHER],"[TREATS]
[OTHER]",increase the rate of acclimatization,N/A,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 12:20:06,1633624004,5/10/2015 12:19:46,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION],[MANIFESTATION],ACETAZOLAMIDE AMS,RELATED,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 12:20:41,1633624130,5/10/2015 12:19:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,AMS can be masked by  ACETAZOLAMIDE,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 12:33:23,1633627077,5/10/2015 12:32:23,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],masks the symptoms,N/A,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 12:50:22,1633631244,5/10/2015 12:50:07,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],masks the symptoms,N/A,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 13:06:15,1633635325,5/10/2015 13:04:57,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SIDE_EFFECT],[SIDE_EFFECT],increase,Side effect,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 13:06:39,1633635509,5/10/2015 13:06:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[MANIFESTATION],[MANIFESTATION],masks,n/a,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 13:15:36,1633637718,5/10/2015 13:15:12,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],masks the symptoms,n/a,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 13:28:45,1633640982,5/10/2015 13:27:58,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[SYMPTOM],[SYMPTOM],masks symptoms,N/A,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 13:30:40,1633641496,5/10/2015 13:29:38,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[SIDE_EFFECT],[SIDE_EFFECT],masks the symptoms of AMS,N/A,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227327,5/10/2015 13:32:28,1633642049,5/10/2015 13:32:14,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],does,jgj,109,9,-1,111,22,TWrex-cause,803535-FS1,• Unlike ACETAZOLAMIDE dexamethasone does not increase the rate of acclimatization but masks the symptoms of AMS resulting in 'rebound' when it is withdrawn,AMS,ACETAZOLAMIDE
718227328,5/10/2015 13:53:54,1633647630,5/10/2015 13:53:39,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],with,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:04:56,1633650295,5/10/2015 14:04:30,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE treatment.,N/a,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:10:40,1633651877,5/10/2015 14:10:11,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],treatment.,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:12:13,1633652269,5/10/2015 14:11:37,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment.,n/a,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:18:28,1633654039,5/10/2015 14:18:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],with treatment.,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:32:41,1633657677,5/10/2015 14:32:28,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:46:54,1633661388,5/10/2015 14:44:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],with FLUCONAZOLE treatment.,treats,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:48:45,1633661870,5/10/2015 14:48:00,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],FLUCONAZOLE,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 14:51:07,1633662550,5/10/2015 14:50:54,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment.,n/a,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 15:04:51,1633666087,5/10/2015 15:03:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE treatment.,n/a,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 15:12:45,1633668160,5/10/2015 15:12:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Favourable outcome,DID NOT SELECT NONE,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 15:15:40,1633668819,5/10/2015 15:14:42,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],BLASTOMYCOSIS with FLUCONAZOLE treatment.,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 15:18:56,1633669670,5/10/2015 15:17:05,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],stem with treatment.,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 16:07:44,1633682357,5/10/2015 16:07:17,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227328,5/10/2015 16:10:47,1633683109,5/10/2015 16:08:39,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],Favourable outcome BLASTOMYCOSIS OF THE BRAIN FLUCONAZOLE treatment.,N/A,64,101,-1,89,112,TWrex-cause,800785-FS1,"Taillan B, Ferrari E, Cosnefroy JY et al. Favourable outcome of BLASTOMYCOSIS OF THE BRAIN stem with FLUCONAZOLE and flucytosine treatment.",BLASTOMYCOSIS OF THE BRAIN,FLUCONAZOLE
718227329,5/10/2015 11:20:59,1633611077,5/10/2015 11:19:26,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,N/A,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:28:21,1633612601,5/10/2015 11:28:03,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],initial treatment,n/a,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:31:57,1633613500,5/10/2015 11:30:35,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],with MAJOR DEPRESSIVE DISORDER who failed with SERTRALINE,n/a,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:41:32,1633615617,5/10/2015 11:39:31,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,MAJOR DEPRESSIVE DISORDER did not respond to SERTRALINE,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:42:17,1633615787,5/10/2015 11:41:58,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],who,2,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:43:21,1633616002,5/10/2015 11:42:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment with,N/A,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:44:20,1633616158,5/10/2015 11:43:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment with,n/a,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:49:18,1633617361,5/10/2015 11:48:51,false,prodege,1.0,22031444,GBR,M4,Southampton,78.146.6.207,[TREATS],[TREATS],treatment,N/a,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 11:52:24,1633618143,5/10/2015 11:50:51,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],treatment,Sertraline is a treatment,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 12:10:01,1633621836,5/10/2015 12:09:34,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,ITS A DIFFERENT KIND OF TABLET,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 12:17:22,1633623300,5/10/2015 12:16:46,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treatment with,N/A,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 12:26:22,1633625454,5/10/2015 12:25:24,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[TREATS],[TREATS],treatment,N/A,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 12:30:16,1633626315,5/10/2015 12:29:34,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[NONE],[NONE],N/A,"""Failed initial treatment""",38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 12:48:29,1633630663,5/10/2015 12:47:14,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],initial treatment with,n/a,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227329,5/10/2015 12:51:30,1633631601,5/10/2015 12:50:27,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treatment,Treated,38,98,-1,62,108,TWrex-cause,800787-FS1,Fluoxetine treatment of patients with MAJOR DEPRESSIVE DISORDER who failed initial treatment with SERTRALINE,MAJOR DEPRESSIVE DISORDER,SERTRALINE
718227330,5/10/2015 13:51:57,1633647098,5/10/2015 13:51:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],recurrent,N/A,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 13:58:26,1633648668,5/10/2015 13:57:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],TROPICAL PULMONARY EOSINOPHILIA uncommon manifestation with recurrent EOSINOPHILIA,N/a,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:05:51,1633650590,5/10/2015 14:05:15,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[MANIFESTATION],[MANIFESTATION],uncommon manifestation,N/A,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:06:28,1633650759,5/10/2015 14:05:44,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[MANIFESTATION],[MANIFESTATION],uncommon manifestation,n/a,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:15:55,1633653308,5/10/2015 14:15:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],manifestation,N/A,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:31:24,1633657360,5/10/2015 14:30:55,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[LOCATION] [CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:39:00,1633659428,5/10/2015 14:36:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],with marked,causes,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:42:01,1633660233,5/10/2015 14:40:26,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],manifestation,N/A,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 14:45:34,1633661166,5/10/2015 14:44:59,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],and marked,n/a,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 15:00:11,1633664792,5/10/2015 14:59:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[MANIFESTATION],[MANIFESTATION],TROPICAL PULMONARY EOSINOPHILIA (TPE) is an manifestation with EOSINOPHILIA,n/a,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 15:05:52,1633666395,5/10/2015 15:04:05,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],manifestation recurrent,N/A,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 15:07:13,1633666752,5/10/2015 15:06:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],manifestation,DID NOT SELECT NONE,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 15:07:25,1633666815,5/10/2015 15:06:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],TROPICAL PULMONARY EOSINOPHILIA uncommon manifestation with EOSINOPHILIA,N/A,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 15:42:36,1633675966,5/10/2015 15:42:02,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[SYMPTOM],[SYMPTOM],with,n/a,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227330,5/10/2015 15:48:10,1633677602,5/10/2015 15:47:19,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"transitory lung infiltrates, low grade fever,",n/a,19,0,1,30,31,TWrex-cause,813979-FS1,"TROPICAL PULMONARY EOSINOPHILIA (TPE)  is an uncommon manifestation with recurrent bronchospasm, transitory lung infiltrates, low grade fever, and marked EOSINOPHILIA",EOSINOPHILIA,TROPICAL PULMONARY EOSINOPHILIA
718227331,5/10/2015 13:11:26,1633636826,5/10/2015 13:11:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],preventing recurrence,n/a,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:26:26,1633640395,5/10/2015 13:25:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],preventing,n/a,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:38:34,1633643675,5/10/2015 13:38:20,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],colleagues,fsdf,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:43:18,1633644841,5/10/2015 13:42:36,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],SOTALOL preventing AF,N/a,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:43:43,1633644983,5/10/2015 13:42:59,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[PREVENTS],[PREVENTS],preventing recurrence,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:43:47,1633644993,5/10/2015 13:43:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],preventing,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:43:54,1633645003,5/10/2015 13:43:21,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[PREVENTS],[PREVENTS],SOTALOL preventing first recurrence of AF,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:46:46,1633645757,5/10/2015 13:46:15,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[PREVENTS],[PREVENTS],preventing,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:47:08,1633645856,5/10/2015 13:44:20,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[PREVENTS],[PREVENTS],preventing,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 13:49:13,1633646441,5/10/2015 13:48:51,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],preventing,n/a,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 14:14:52,1633652996,5/10/2015 14:13:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],in preventing,although other drugs work better,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 14:22:04,1633654859,5/10/2015 14:20:56,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],propafenone,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 14:24:58,1633655711,5/10/2015 14:24:38,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [LOCATION] [SYMPTOM] [NONE],"[PREVENTS]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 14:37:02,1633658811,5/10/2015 14:36:27,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],preventing,n/a,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227331,5/10/2015 14:37:24,1633658960,5/10/2015 14:36:32,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[PREVENTS],[PREVENTS],preventing recurrence,N/A,213,169,-1,214,176,TWrex-cause,805040-FS1,"COMMENTARY  This interesting trial by Roy and colleagues showed that amiodarone, in low doses by North American standards, was more effective than either propafenone or SOTALOL in preventing a first recurrence of AF",AF,SOTALOL
718227332,5/10/2015 11:41:27,1633615608,5/10/2015 11:41:00,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],eliminates,n/a,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 11:52:08,1633618092,5/10/2015 11:50:37,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases,N/A,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 11:54:13,1633618462,5/10/2015 11:53:43,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PREVENTS],[PREVENTS],virtually eliminates,n/a,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 12:07:32,1633621226,5/10/2015 12:04:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PART_OF],[PART_OF],Splenectomy virtually eliminates HEMOLYSIS in common forms of,n/a,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 12:17:03,1633623230,5/10/2015 12:16:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",in common forms of,N/A,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 12:26:07,1633625406,5/10/2015 12:24:52,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],common forms,COMMON FORMS INPLIES ITS IS RELATED TOO,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 12:28:07,1633625926,5/10/2015 12:26:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,There is no relation shown between HEMOLYSIS and   HEREDITARY SPHEROCYTOSIS,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 12:37:59,1633628100,5/10/2015 12:36:56,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",in common forms of,N/A,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 12:54:01,1633632110,5/10/2015 12:53:00,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],in common forms of,N/A,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 13:08:57,1633636136,5/10/2015 13:08:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],virtually eliminates,n/a,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 13:09:48,1633636342,5/10/2015 13:09:15,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],forms,Symptom,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 13:20:36,1633639011,5/10/2015 13:20:08,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in common forms of,n/a,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 13:35:27,1633642873,5/10/2015 13:34:42,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[PREVENTS],[PREVENTS],common,fbfg,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 13:37:28,1633643444,5/10/2015 13:36:22,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS,N/A,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227332,5/10/2015 13:39:01,1633643767,5/10/2015 13:38:30,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[TREATS],[TREATS],performed mildest cases,N/A,45,74,1,53,98,TWrex-cause,813066-FS1,Evidence: • Splenectomy virtually eliminates HEMOLYSIS in common forms of HEREDITARY SPHEROCYTOSIS and it should be performed in all but the mildest cases ( 31 ;  32 ;  33.,HEMOLYSIS,HEREDITARY SPHEROCYTOSIS
718227333,5/10/2015 15:23:15,1633671007,5/10/2015 15:22:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],involved with,N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 15:31:26,1633673207,5/10/2015 15:30:37,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[CAUSES],[CAUSES],"rare condition,",N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 16:21:46,1633686065,5/10/2015 16:21:09,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[SYMPTOM],[SYMPTOM],SYSTEMIC MASTOCYTOSIS the SKIN are involved with proliferating mast cells.,N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 16:22:12,1633686194,5/10/2015 16:21:37,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[LOCATION],[LOCATION],are involved with,n/a,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 16:24:04,1633686710,5/10/2015 16:23:37,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],SYSTEMIC MASTOCYTOSIS SKIN,N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 16:31:01,1633688578,5/10/2015 16:29:36,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[LOCATION],[LOCATION],involved with proliferating mast cells.,N/a,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 16:47:29,1633693350,5/10/2015 16:46:51,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],are involved with proliferating mast cells.,n/a,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 16:59:02,1633696667,5/10/2015 16:58:25,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[LOCATION],[LOCATION],involved,N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 17:34:59,1633707345,5/10/2015 17:34:29,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[SIDE_EFFECT],[SIDE_EFFECT],"In this rare condition, the cases),",I didn´t select none.,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 18:23:40,1633722022,5/10/2015 18:23:14,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"condition,",N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 18:44:28,1633729588,5/10/2015 18:42:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],proliferating mast cells.,N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 19:03:29,1633739401,5/10/2015 19:02:54,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],"SYSTEMIC MASTOCYTOSIS this rare condition, SKIN of bones (9%), (12%), spleen (11%), lymph GI are involved with proliferating mast cells.",na,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 19:12:07,1633743414,5/10/2015 19:10:47,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",involved with,N/A,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 19:17:33,1633750442,5/10/2015 19:16:24,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",involved,n/a,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227333,5/10/2015 19:22:04,1633752485,5/10/2015 19:21:28,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.213,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,51,0,-1,54,21,TWrex-cause,802297-FS1,"SYSTEMIC MASTOCYTOSIS  In this rare condition, the SKIN (99% of cases), bones (9%), liver (12%), spleen (11%), lymph nodes, and GI tract are involved with proliferating mast cells.",SKIN,SYSTEMIC MASTOCYTOSIS
718227334,5/10/2015 13:49:56,1633646598,5/10/2015 13:49:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy therapy,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 13:55:45,1633648026,5/10/2015 13:54:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ARSENIC TRIOXIDE alternative chemotherapy APL,N/a,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:02:40,1633649693,5/10/2015 14:01:44,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],been used therapy,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:03:31,1633649946,5/10/2015 14:01:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],used as an alternative to chemotherapy,n/a,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:12:42,1633652421,5/10/2015 14:12:09,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],used as an alternative,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:29:44,1633656954,5/10/2015 14:29:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [LOCATION] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:32:44,1633657705,5/10/2015 14:31:28,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy,alternate treatment,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:37:02,1633658815,5/10/2015 14:35:00,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],ARSENIC TRIOXIDE,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:43:52,1633660834,5/10/2015 14:43:24,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Combination therapy alternative to chemotherapy,n/a,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:55:56,1633663879,5/10/2015 14:55:26,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],used as an alternative to chemotherapy,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:57:37,1633664242,5/10/2015 14:56:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ARSENIC TRIOXIDE alternative to chemotherapy for APL,n/a,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 14:59:15,1633664605,5/10/2015 14:58:52,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],postremission diagnosed,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 15:02:28,1633665345,5/10/2015 15:00:31,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Combination therapy ARSENIC TRIOXIDE tretinoin alternative chemotherapy induction postremission therapy newly diagnosed APL,N/A,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 15:03:45,1633665778,5/10/2015 15:02:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,DID NOT SELECT NONE,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227334,5/10/2015 15:38:58,1633675178,5/10/2015 15:38:05,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],has been used,Arsenic trioxide is used to treat APL,181,43,-1,183,59,TWrex-cause,803784-FS1,"17 ,   20 ,   25  Combination therapy with ARSENIC TRIOXIDE and tretinoin has been used as an alternative to chemotherapy for induction and postremission therapy in newly diagnosed APL   +   ; may consider use of these regimens in select patients who cannot tolerate standard anthracycline containing chemotherapy (e.g., geriatric patients with poor performance or patients with cardiac dysfunction.",APL,ARSENIC TRIOXIDE
718227335,5/10/2015 15:17:36,1633669235,5/10/2015 15:17:07,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM:,n/a,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 15:21:48,1633670636,5/10/2015 15:21:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],THERAPY,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 15:29:53,1633672795,5/10/2015 15:29:17,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[TREATS],[TREATS],new agent.,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:20:42,1633685897,5/10/2015 16:19:58,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM:,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:21:18,1633685988,5/10/2015 16:20:47,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[TREATS],[TREATS],thrombolytic agent.,n/a,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:23:11,1633686447,5/10/2015 16:22:40,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM:,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:25:12,1633686945,5/10/2015 16:24:10,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],THERAPY in,The therapy is used to treat the embolism,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:29:08,1633687956,5/10/2015 16:28:27,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],THERAPY,N/a,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:46:29,1633693042,5/10/2015 16:45:44,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],THERAPY in CLINICAL PULMONARY EMBOLISM:,n/a,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 16:53:28,1633695108,5/10/2015 16:52:53,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],THERAPY thrombolytic agent.,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 17:32:10,1633706744,5/10/2015 17:31:37,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[TREATS],[TREATS],THERAPY,I didn´t select none.,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 18:22:13,1633721570,5/10/2015 18:21:26,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],THERAPY,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 18:42:04,1633728354,5/10/2015 18:40:48,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],THERAPY in,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 19:00:45,1633738357,5/10/2015 19:00:21,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],Sasahara Belko et UROKINASE THERAPY CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.,na,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227335,5/10/2015 19:09:35,1633741248,5/10/2015 19:06:58,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[IS_A] [NONE],"[IS_A]
[NONE]",a new,N/A,63,42,-1,89,59,TWrex-cause,800311-FS1,"Sasahara AA, Cannilla JE, Belko JS et al. UROKINASE THERAPY in CLINICAL PULMONARY EMBOLISM: a new thrombolytic agent.",CLINICAL PULMONARY EMBOLISM,UROKINASE THERAPY
718227336,5/10/2015 11:28:13,1633612573,5/10/2015 11:26:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS,N/A,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 11:32:38,1633613710,5/10/2015 11:32:20,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],"(eg,",n/a,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 11:38:28,1633614980,5/10/2015 11:36:28,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[IS_A],[IS_A],secondary to,n/a,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 11:48:18,1633617101,5/10/2015 11:47:38,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],"(eg,",n/a,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 11:52:37,1633618208,5/10/2015 11:50:07,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],"(eg,",none,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 11:58:55,1633619474,5/10/2015 11:58:06,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A] [PART_OF],"[IS_A]
[PART_OF]","(eg,",N/A,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 12:13:00,1633622404,5/10/2015 12:12:38,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION],[MANIFESTATION],CEREBRAL PALSY,THEY ARE RELATED,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 12:21:11,1633624249,5/10/2015 12:20:25,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],"(eg,",N/A,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 12:31:34,1633626705,5/10/2015 12:30:31,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[IS_A],[IS_A],"(eg,",N/A,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 12:33:34,1633627110,5/10/2015 12:33:06,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[IS_A],[IS_A],"(eg,",N/A,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 12:56:11,1633632727,5/10/2015 12:54:11,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM] [PART_OF],"[SYMPTOM]
[PART_OF]","(eg,",n/a,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 12:56:50,1633632938,5/10/2015 12:56:00,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PART_OF],[PART_OF],"(eg,",An example of,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 13:02:19,1633634342,5/10/2015 13:01:58,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],secondary to,n/a,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 13:02:24,1633634348,5/10/2015 13:01:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],"(eg,",n/a,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227336,5/10/2015 13:18:42,1633638480,5/10/2015 13:16:54,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DEGENERATIVE DISORDERS CEREBRAL PALSY,N/A,53,163,-1,91,177,TWrex-cause,802854-FS1,"Dystonia may be primary (idiopathic) or secondary to DEGENERATIVE OR METABOLIC CNS DISORDERS (eg, Wilson's disease, Hallervorden Spatz disease, various lipidoses, CEREBRAL PALSY stroke) or drugs (most often phenothiazines, thioxanthenes, butyrophenones, and antiemetics.",DEGENERATIVE OR METABOLIC CNS DISORDERS,CEREBRAL PALSY
718227337,5/10/2015 11:36:43,1633614687,5/10/2015 11:36:29,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],resistant,n/a,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 11:39:03,1633615160,5/10/2015 11:36:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],M TUBERCULOSIS resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,N/A,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 11:45:38,1633616502,5/10/2015 11:44:36,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],resistant to,n/a,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 11:55:03,1633618621,5/10/2015 11:52:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],resistant to,"the intent is to treat, but it is not effective",6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 12:05:40,1633620919,5/10/2015 12:04:52,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS] [OTHER],"[TREATS]
[OTHER]",resistant to,N/A,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 12:14:29,1633622675,5/10/2015 12:13:24,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,M TUBERCULOSIS is resistant to  RIFAMPIN,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 12:16:50,1633623170,5/10/2015 12:16:07,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[PREVENTS],[PREVENTS],resistant,STOPS,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 12:28:24,1633626060,5/10/2015 12:27:21,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,There appears to be no relation.,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 12:38:04,1633628120,5/10/2015 12:37:19,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[OTHER],[OTHER],resistant to,N/A,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 12:48:28,1633630654,5/10/2015 12:48:06,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[OTHER],[OTHER],resistant to,N/A,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 13:02:07,1633634294,5/10/2015 13:01:24,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],resistant,Resistant,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 13:05:10,1633635099,5/10/2015 13:04:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],resistant to,n/a,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 13:06:43,1633635537,5/10/2015 13:04:15,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CONTRAINDICATES],[CONTRAINDICATES],resistant to,n/a,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 13:07:50,1633635799,5/10/2015 13:07:28,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],resistant to,n/a,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227337,5/10/2015 13:24:35,1633639949,5/10/2015 13:23:45,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[CONTRAINDICATES],[CONTRAINDICATES],resistant,N/A,6,54,-1,19,62,TWrex-cause,804912-FS1,a •   M TUBERCULOSIS  resistant to both isoniazid and RIFAMPIN (MDR TB) occurs.,M TUBERCULOSIS,RIFAMPIN
718227338,5/10/2015 11:43:26,1633616008,5/10/2015 11:42:48,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],be treated,n/a,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 11:54:59,1633618618,5/10/2015 11:53:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated,N/A,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 11:55:14,1633618663,5/10/2015 11:54:50,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],be treated with,n/a,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 12:08:38,1633621474,5/10/2015 12:08:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],be treated with,n/a,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 12:18:46,1633623625,5/10/2015 12:18:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treated with,N/A,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 12:26:46,1633625564,5/10/2015 12:26:34,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treated,TREATS,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 12:30:34,1633626420,5/10/2015 12:29:22,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,ANEMIA OF CKD can be treated with EPOETIN ALFA,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 12:40:01,1633628629,5/10/2015 12:39:41,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],be treated with,N/A,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 12:54:45,1633632334,5/10/2015 12:54:18,false,instagc,1,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS] [OTHER],"[TREATS]
[OTHER]",treated with,treated by,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 13:09:42,1633636341,5/10/2015 13:09:28,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],be treated with,n/a,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 13:11:03,1633636693,5/10/2015 13:10:23,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],treated,Treated with,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 13:21:45,1633639298,5/10/2015 13:21:15,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treated with,n/a,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 13:36:14,1633643053,5/10/2015 13:35:57,false,superrewards,1,32459436,USA,DE,"",108.59.8.210,[PREVENTS],[PREVENTS],ANEMIA,dcc,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 13:38:48,1633643718,5/10/2015 13:38:18,false,coinworker,1,20231698,USA,"","",172.56.32.19,[TREATS],[TREATS],ANEMIA OF CKD treated with EPOETIN ALFA,N/A,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227338,5/10/2015 13:39:20,1633643824,5/10/2015 13:38:33,false,clixsense,1,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],treated,N/A,60,90,-1,72,102,TWrex-cause,803945-FS1,• Clinical practice guidelines recommend that patients with ANEMIA OF CKD be treated with EPOETIN ALFA as well as replacement or maintenance doses of parenteral iron if indicated ( 69.,ANEMIA OF CKD,EPOETIN ALFA
718227339,5/10/2015 11:38:25,1633614976,5/10/2015 11:38:10,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],characterized by,n/a,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 11:44:10,1633616141,5/10/2015 11:43:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","Rationale: PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",N/A,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 11:50:02,1633617564,5/10/2015 11:49:25,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n.a,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 11:59:02,1633619485,5/10/2015 11:58:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],is characterized by,n/a,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 12:12:12,1633622245,5/10/2015 12:11:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",characterized by,N/A,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 12:21:10,1633624246,5/10/2015 12:20:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[LOCATION],[LOCATION],characterized,CHARACTERIZED,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 12:21:36,1633624342,5/10/2015 12:20:42,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],characterized by,none,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 12:34:14,1633627210,5/10/2015 12:33:24,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",AND,N/A,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 12:50:37,1633631323,5/10/2015 12:50:23,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],is characterized by,N/A,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 13:06:49,1633635589,5/10/2015 13:06:16,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],characterized,Symptom,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 13:07:02,1633635643,5/10/2015 13:06:40,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 13:16:58,1633638067,5/10/2015 13:15:37,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],is characterized by,n/a,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 13:31:01,1633641666,5/10/2015 13:28:47,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[SYMPTOM],[SYMPTOM],"thrombohemorrhagic complications, symptoms,",N/A,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 13:31:32,1633641789,5/10/2015 13:30:42,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[PART_OF],[PART_OF],PV is characterized by AQUAGENIC PRURITUS AND SPLENOMEGALY,N/A,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227339,5/10/2015 13:32:08,1633641942,5/10/2015 13:31:29,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[LOCATION],[LOCATION],thrombohemorrhagic,kkkkkkkkkkkkkkkkkkl,90,13,1,124,15,TWrex-cause,812658-FS1,"Rationale: • PV is characterized by thrombohemorrhagic complications, vasomotor symptoms, AQUAGENIC PRURITUS AND SPLENOMEGALY",AQUAGENIC PRURITUS AND SPLENOMEGALY,PV
718227340,5/10/2015 14:55:34,1633663836,5/10/2015 14:55:20,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment,n/a,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 15:09:48,1633667457,5/10/2015 15:07:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],treatment with 20% AZELAIC ACID CREAM for ACNE,n/a,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 15:16:07,1633669001,5/10/2015 15:15:47,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 15:22:37,1633670838,5/10/2015 15:22:02,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[OTHER],[OTHER],studies for,N/A,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 15:23:28,1633671098,5/10/2015 15:22:37,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],treatment with AZELAIC ACID CREAM for ACNE,N/A,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:13:55,1633683980,5/10/2015 16:13:31,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],treatment AZELAIC ACID CREAM for ACNE,N/A,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:15:53,1633684569,5/10/2015 16:15:27,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[NONE],[NONE],n/a,Needs IS TREATED WITH,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:16:12,1633684679,5/10/2015 16:15:31,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],studies 20% AZELAIC ACID CREAM ACNE,N/A,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:18:43,1633685391,5/10/2015 16:18:05,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],treatment with,The cream is used to treat acne,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:22:52,1633686399,5/10/2015 16:22:32,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],treatment,N/a,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:39:27,1633690974,5/10/2015 16:38:45,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],treatment with,there is a relation,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 16:48:12,1633693553,5/10/2015 16:47:36,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],treatment,N/A,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 17:02:28,1633697516,5/10/2015 17:01:54,false,instagc,1,23035364,USA,"","",73.29.106.28,[TREATS],[TREATS],treatment,no,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 17:07:47,1633699055,5/10/2015 17:07:08,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],treatment for,n/a,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227340,5/10/2015 17:27:21,1633705309,5/10/2015 17:24:25,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[MANIFESTATION],[MANIFESTATION],treatment for,I didn´t select none.,77,50,-1,80,72,TWrex-cause,800834-FS1,Clinical and laboratory studies on treatment with 20% AZELAIC ACID CREAM for ACNE,ACNE,20% AZELAIC ACID CREAM
718227341,5/10/2015 13:53:38,1633647587,5/10/2015 13:53:06,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treating,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:04:29,1633650156,5/10/2015 14:03:59,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],INH treating TB,N/a,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:10:09,1633651737,5/10/2015 14:09:38,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],potent in treating,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:11:36,1633652135,5/10/2015 14:11:16,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treating,n/a,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:17:58,1633653867,5/10/2015 14:17:32,false,bitcoinget,1,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],treating,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:32:26,1633657623,5/10/2015 14:32:13,false,neodev,1,32103286,USA,CA,San Jose,23.27.248.125,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:44:54,1633661031,5/10/2015 14:43:41,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treating,treatment,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:47:59,1633661679,5/10/2015 14:47:32,false,clixsense,1,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],rifampicin resistance.,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 14:50:54,1633662484,5/10/2015 14:49:01,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],potent in treating,n/a,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 15:03:44,1633665765,5/10/2015 15:03:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],INH is potent in treating TB,n/a,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 15:12:02,1633668010,5/10/2015 15:11:31,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treating,DID NOT SELECT NONE,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 15:14:42,1633668535,5/10/2015 15:13:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],INH is potent in treating TB,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 15:17:04,1633669159,5/10/2015 15:15:08,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[OTHER],[OTHER],treating,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 16:07:16,1633682290,5/10/2015 16:06:52,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],INH is so potent in treating TB,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227341,5/10/2015 16:15:29,1633684468,5/10/2015 16:14:29,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],INH potent treating TB,N/A,83,42,-1,84,45,TWrex-cause,803948-FS1,The reason for maintaining the patient on INH is that INH is so potent in treating TB that it is foolish to omit it until there is microbiological proof that it is ineffective (even though isoniazid resistance so commonly occurs with rifampicin resistance.,TB,INH
718227342,5/10/2015 15:12:31,1633668133,5/10/2015 15:11:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],INFLUENZA activity marked by FEBRILE RESPIRATORY ILLNESS,n/a,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 15:18:39,1633669629,5/10/2015 15:17:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[MANIFESTATION],[MANIFESTATION],increased contacts,N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 15:25:22,1633671599,5/10/2015 15:23:58,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],increased hospitalizations,N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 15:30:18,1633672974,5/10/2015 15:29:18,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]","INFLUENZA is FEBRILE RESPIRATORY ILLNESS and cardiopulmonary disorders,",N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:15:54,1633684573,5/10/2015 16:15:16,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],INFLUENZA is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS,N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:17:38,1633685139,5/10/2015 16:17:05,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[CAUSES],[CAUSES],is marked by,n/a,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:19:49,1633685652,5/10/2015 16:17:53,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],INFLUENZA activity marked by increased FEBRILE RESPIRATORY ILLNESS,N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:20:43,1633685902,5/10/2015 16:20:08,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[ASSOCIATED_WITH],[ASSOCIATED_WITH],marked by,n/a,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:25:03,1633686915,5/10/2015 16:24:32,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[MANIFESTATION],[MANIFESTATION],is marked by,N/a,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:42:01,1633691706,5/10/2015 16:40:57,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[NONE],[NONE],N/A,"They are only saying that the effect of have the flu is that people miss school, work, etc.",0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 16:50:30,1633694237,5/10/2015 16:49:38,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[IS_A],[IS_A],increased medical contacts,N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 17:03:10,1633697712,5/10/2015 17:03:00,false,instagc,1.0,23035364,USA,"","",73.29.106.28,[TREATS],[TREATS],contacts,n/a,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 17:21:18,1633703266,5/10/2015 17:20:42,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",marked by increased medical contacts for,n/a,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 17:29:12,1633705838,5/10/2015 17:28:39,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[CAUSES],[CAUSES],marked by increased medical contacts,I didn´t select none.,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227342,5/10/2015 18:17:22,1633720072,5/10/2015 18:16:59,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],increased,N/A,0,80,1,8,107,TWrex-cause,811728-FS1,"INFLUENZA activity in the community is marked by increased medical contacts for FEBRILE RESPIRATORY ILLNESS increased absenteeism from school and the workplace, subsequent increased hospitalizations for pneumonia and other cardiopulmonary disorders, and increased mortality.",INFLUENZA,FEBRILE RESPIRATORY ILLNESS
718227343,5/10/2015 13:55:49,1633648038,5/10/2015 13:55:04,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,same activity as. So it's not actually vitamin k,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 14:06:51,1633650833,5/10/2015 14:06:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],VITAMIN K disorders HYPOPROTHROMBINEMIA.,N/a,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 14:14:10,1633652794,5/10/2015 14:13:40,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],is used as an antihemorrhagic agent,n/a,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 14:51:35,1633662639,5/10/2015 14:50:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],is used,used to treat,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 14:52:34,1633662893,5/10/2015 14:52:00,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HYPOPROTHROMBINEMIA.,N/A,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 14:55:19,1633663774,5/10/2015 14:55:00,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],used as an antihemorrhagic agent,n/a,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 15:07:51,1633666921,5/10/2015 15:07:01,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],VITAMIN K used as antihemorrhagic agent in disorders due to HYPOPROTHROMBINEMIA.,n/a,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 15:15:46,1633668839,5/10/2015 15:15:03,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],is used as an antihemorrhagic,N/A,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 15:22:00,1633670690,5/10/2015 15:20:59,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[PART_OF],[PART_OF],used as an antihemorrhagic agent,N/A,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 15:22:36,1633670835,5/10/2015 15:20:54,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],VITAMIN K is used as an antihemorrhagic agent in hypoprothrombinemia,N/A,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 16:13:29,1633683844,5/10/2015 16:13:04,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],VITAMIN K is used as an antihemorrhagic agent due to HYPOPROTHROMBINEMIA.,N/A,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 16:14:28,1633684166,5/10/2015 16:13:23,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],VITAMIN K used antihemorrhagic agent in HYPOPROTHROMBINEMIA.,N/A,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 16:15:25,1633684459,5/10/2015 16:14:03,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[NONE],[NONE],n/a,vitamin A is not the focus of the sentence,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 16:18:04,1633685199,5/10/2015 16:17:01,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[NONE],[NONE],n/a,The link is between MSD and HYPOPROTHROMBINEMIA,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227343,5/10/2015 16:22:31,1633686279,5/10/2015 16:21:26,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],is used as an antihemorrhagic agent,N/a,228,124,-1,246,133,TWrex-cause,805050-FS1,menadiol sodium diphosphate    (               audio )  A synthetic water soluble vitamin with the same activity as natural VITAMIN K It is used as an antihemorrhagic agent in hypoprothrombinemia or hemorrhagic disorders due to HYPOPROTHROMBINEMIA.,HYPOPROTHROMBINEMIA,VITAMIN K
718227344,5/10/2015 11:35:36,1633614348,5/10/2015 11:34:56,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,N/A,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 11:36:09,1633614548,5/10/2015 11:35:50,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[MANIFESTATION],[MANIFESTATION],presenting,n/a,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 11:43:23,1633616007,5/10/2015 11:42:58,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[MANIFESTATION],[MANIFESTATION],presenting,n/a,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 11:51:49,1633618037,5/10/2015 11:51:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],presenting as,n/a,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 12:04:03,1633620584,5/10/2015 12:03:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",presenting as,N/A,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 12:11:54,1633622192,5/10/2015 12:10:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,SPONTANEOUS SPLENIC RUPTURE   can be caused by   INFECTIOUS MONONUCLEOSIS,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 12:15:41,1633622929,5/10/2015 12:15:19,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],presenting,PRESENTING SAYS IT IS SYMTOM,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 12:26:15,1633625439,5/10/2015 12:25:38,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION],[MANIFESTATION],presenting as,N/A,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 12:36:03,1633627598,5/10/2015 12:35:23,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",symptoms.,N/A,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 12:40:45,1633628871,5/10/2015 12:40:29,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],presenting as,N/A,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 13:00:24,1633633860,5/10/2015 12:59:49,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],presenting,Presents as,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 13:01:42,1633634143,5/10/2015 13:00:41,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[IS_A],[IS_A],presenting as,n/a,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 13:04:31,1633634881,5/10/2015 13:04:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presenting as,n/a,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 13:06:48,1633635581,5/10/2015 13:06:28,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],presenting as,n/a,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227344,5/10/2015 13:24:28,1633639925,5/10/2015 13:22:33,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[SYMPTOM],[SYMPTOM],without other symptoms.,N/A,39,0,1,65,24,TWrex-cause,813471-FS1,INFECTIOUS MONONUCLEOSIS presenting as SPONTANEOUS SPLENIC RUPTURE without other symptoms.,SPONTANEOUS SPLENIC RUPTURE,INFECTIOUS MONONUCLEOSIS
718227345,5/10/2015 16:22:46,1633686376,5/10/2015 16:22:31,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[TREATS],[TREATS],should be treated initially with,n/a,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 16:23:08,1633686431,5/10/2015 16:22:43,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],DECOMPRESSION SICKNESS should be treated with oxygen,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 16:25:02,1633686916,5/10/2015 16:24:34,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],DECOMPRESSION SICKNESS should treated with OXYGEN therapy,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 16:32:02,1633688895,5/10/2015 16:31:39,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],treated,N/a,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 16:48:16,1633693563,5/10/2015 16:47:50,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],should be treated initially with 100% oxygen,n/a,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 17:00:16,1633697000,5/10/2015 16:59:40,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],treated initially,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 17:36:36,1633707829,5/10/2015 17:36:17,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[TREATS],[TREATS],should be treated initially,I didn´t select none.,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 18:24:31,1633722350,5/10/2015 18:24:13,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treated,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 18:46:10,1633730489,5/10/2015 18:45:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treated initially with,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 19:04:59,1633739798,5/10/2015 19:04:04,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],"Further information: Hyperbaric medicine cases DECOMPRESSION should initially 100% oxygen hyperbaric OXYGEN therapy (100% delivered high pressure chamber) be provided.[69] 'bends' and some skin symptoms disappear during descent however, recommended that be evaluated",na,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 19:14:02,1633745899,5/10/2015 19:13:24,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",treated,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 19:18:52,1633751029,5/10/2015 19:18:18,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treated,n/a,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 19:48:46,1633770413,5/10/2015 19:47:37,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],DECOMPRESSION SICKNESS should be treated with 100% oxygen until hyperbaric OXYGEN therapy,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 20:12:38,1633779746,5/10/2015 20:11:54,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.112,[TREATS],[TREATS],should be treated,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227345,5/10/2015 20:28:51,1633784465,5/10/2015 20:26:07,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[TREATS],[TREATS],should be treated initially with,N/A,55,140,-1,76,146,TWrex-cause,800162-FS1,"Further information: Hyperbaric medicine  All cases of DECOMPRESSION SICKNESS should be treated initially with 100% oxygen until hyperbaric OXYGEN therapy (100% oxygen delivered in a high pressure chamber) can be provided.[69] Mild cases of the 'bends' and some skin symptoms may disappear during descent from high altitude; however, it is recommended that these cases still be evaluated",DECOMPRESSION SICKNESS,OXYGEN
718227346,5/10/2015 13:51:30,1633646973,5/10/2015 13:51:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 13:57:40,1633648495,5/10/2015 13:57:13,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Treatment METASTATIC RENAL CARCINOMA with INTERFERON ALFA,N/a,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:05:13,1633650421,5/10/2015 14:04:34,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],Treatment,N/A,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:05:43,1633650548,5/10/2015 14:05:10,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],Treatment,n/a,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:15:26,1633653172,5/10/2015 14:15:00,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],Treatment of,N/A,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:30:54,1633657220,5/10/2015 14:30:31,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [TREATS] [NONE],"[TREATS]
[PREVENTS]
[NONE]",no,no,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:36:51,1633658769,5/10/2015 14:35:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Treatment,used in combination with other drug,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:40:24,1633659841,5/10/2015 14:38:27,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],RENAL CARCINOMA,N/A,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:44:58,1633661042,5/10/2015 14:44:44,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],Treatment,n/a,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 14:59:33,1633664692,5/10/2015 14:58:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],METASTATIC RENAL CARCINOMA with INTERFERON ALFA,n/a,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 15:04:05,1633665862,5/10/2015 15:02:56,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combination,N/A,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 15:06:17,1633666556,5/10/2015 15:05:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Treatment,DID NOT SELECT NONE,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 15:06:20,1633666563,5/10/2015 15:04:58,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Treatment of patients with METASTATIC RENAL CARCINOMA with INTERFERON ALFA,N/A,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 15:40:58,1633675631,5/10/2015 15:40:05,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],Treatment of patients with a combination of,n/a,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227346,5/10/2015 15:42:00,1633675885,5/10/2015 15:41:27,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],Treatment,Interferon treats the carcinoma,64,144,-1,89,159,TWrex-cause,803792-FS1,"Negrier S, Caty A, Lesimple T et al. Treatment of patients with METASTATIC RENAL CARCINOMA with a combination of subcutaneous interleukin 2 and INTERFERON ALFA with or without fluorouracil.",METASTATIC RENAL CARCINOMA,INTERFERON ALFA
718227347,5/10/2015 11:44:21,1633616153,5/10/2015 11:43:44,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],therapy,n/a,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 11:57:13,1633619119,5/10/2015 11:56:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",N/A,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:01:27,1633620072,5/10/2015 12:01:14,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],in therapy of,n/a,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:09:11,1633621638,5/10/2015 12:08:57,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in therapy of,n/a,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:20:39,1633624125,5/10/2015 12:20:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],in therapy of,N/A,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:28:08,1633625938,5/10/2015 12:27:49,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],therapy,TREATS,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:32:54,1633626972,5/10/2015 12:31:57,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,URINARY TRACT INFECTIONS can be treated with  CIPROFLOXACIN,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:40:38,1633628825,5/10/2015 12:40:22,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],in therapy of,N/A,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 12:55:33,1633632592,5/10/2015 12:55:15,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[OTHER] [TREATS],"[TREATS]
[OTHER]",therapy of,treated by,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 13:10:15,1633636461,5/10/2015 13:10:00,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],therapy of,n/a,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 13:11:59,1633636962,5/10/2015 13:11:36,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],therapy,Treated by,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 13:23:01,1633639598,5/10/2015 13:22:33,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],in therapy of,n/a,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 13:36:55,1633643316,5/10/2015 13:36:42,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[CAUSES],[CAUSES],URINARY,cxsx,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 13:40:31,1633644183,5/10/2015 13:39:40,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CIPROFLOXACIN versus therapy of URINARY TRACT INFECTIONS:,N/A,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227347,5/10/2015 13:40:39,1633644239,5/10/2015 13:39:21,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],therapy,N/A,45,0,-1,68,13,TWrex-cause,803795-FS1,"CIPROFLOXACIN versus cinoxacin in therapy of URINARY TRACT INFECTIONS: a randomized, double blind trial.",URINARY TRACT INFECTIONS,CIPROFLOXACIN
718227348,5/10/2015 13:52:18,1633647203,5/10/2015 13:51:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[OTHER],[OTHER],used during,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 13:59:14,1633648895,5/10/2015 13:58:28,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],BENAZEPRIL used during PREGNANCY,N/a,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:07:08,1633650930,5/10/2015 14:05:53,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CONTRAINDICATES],[CONTRAINDICATES],Possible when is used,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:07:43,1633651056,5/10/2015 14:06:29,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],neonatal morbidity and mortality,n/a,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:16:30,1633653414,5/10/2015 14:15:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],is used,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:31:39,1633657434,5/10/2015 14:31:25,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[TREATS] [PREVENTS] [CAUSES] [NONE],"[TREATS]
[PREVENTS]
[CAUSES]
[NONE]",no,no,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:40:07,1633659740,5/10/2015 14:39:01,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],morbidity and mortality when used,causes mobidity,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:42:38,1633660381,5/10/2015 14:42:03,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],PREGNANCY,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 14:46:45,1633661359,5/10/2015 14:45:35,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SIDE_EFFECT],[SIDE_EFFECT],when BENAZEPRIL is used,n/a,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 15:01:04,1633665016,5/10/2015 15:00:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],when BENAZEPRIL is used during PREGNANCY,n/a,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 15:07:55,1633666940,5/10/2015 15:05:53,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],used during,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 15:08:21,1633667054,5/10/2015 15:07:13,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],Possible morbidity,DID NOT SELECT NONE,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 15:08:36,1633667115,5/10/2015 15:07:26,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",Fetal/Neonatal Morbidity and Mortality Possible fetal neonatal morbidity mortality BENAZEPRIL used during PREGNANCY,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 15:43:41,1633676334,5/10/2015 15:42:37,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[CONTRAINDICATES],[CONTRAINDICATES],Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used,n/a,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227348,5/10/2015 16:04:41,1633681735,5/10/2015 16:03:43,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CONTRAINDICATES],[CONTRAINDICATES],morbidity and mortality when BENAZEPRIL is used during PREGNANCY,N/A,140,114,-1,148,124,TWrex-cause,803278-FS1,"1 ,   11 ,   12  Fetal/Neonatal Morbidity and Mortality  Possible fetal and neonatal morbidity and mortality when BENAZEPRIL is used during PREGNANCY",PREGNANCY,BENAZEPRIL
718227349,5/10/2015 13:42:15,1633644590,5/10/2015 13:42:03,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[PREVENTS],[PREVENTS],Excess,sasa,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 13:47:22,1633645917,5/10/2015 13:46:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],causing,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 13:48:38,1633646235,5/10/2015 13:48:19,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],Excess FLUORINE causing FLUOROSIS,N/a,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 13:53:27,1633647527,5/10/2015 13:52:53,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],causing,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 13:56:41,1633648249,5/10/2015 13:55:53,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CAUSES],[CAUSES],causing,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 13:58:28,1633648670,5/10/2015 13:57:47,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],causing,n/a,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:26:05,1633656051,5/10/2015 14:25:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causing,caused by,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:27:50,1633656507,5/10/2015 14:27:22,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[LOCATION] [CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:28:10,1633656551,5/10/2015 14:27:24,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],Toxicity:,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:40:02,1633659731,5/10/2015 14:39:47,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],causing,n/a,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:41:21,1633660076,5/10/2015 14:41:06,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causing,n/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:43:26,1633660705,5/10/2015 14:43:02,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[CAUSES],[CAUSES],causing,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:52:18,1633662829,5/10/2015 14:51:52,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],accumulate,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:53:54,1633663305,5/10/2015 14:53:20,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],FLUORINE can causing FLUOROSIS,n/a,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227349,5/10/2015 14:54:24,1633663485,5/10/2015 14:53:28,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],Excess FLUORINE accumulate causing FLUOROSIS,N/A,107,55,1,115,63,TWrex-cause,810243-FS1,"Fluoridation of water that contains  Toxicity:  Excess FLUORINE can accumulate in teeth and bones, causing FLUOROSIS",FLUOROSIS,FLUORINE
718227350,5/10/2015 11:23:07,1633611494,5/10/2015 11:22:05,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS],[PREVENTS],the prevention of EMESIS due to cisplatin based chemotherapy.,N/A,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:30:10,1633612955,5/10/2015 11:29:28,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[PREVENTS],[PREVENTS],prevention,n/a,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:33:43,1633613906,5/10/2015 11:32:58,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],LORAZEPAM in the prevention of EMESIS,n/a,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:43:12,1633615981,5/10/2015 11:42:50,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[LOCATION],[LOCATION],combination,524,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:45:07,1633616364,5/10/2015 11:42:34,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,EMESIS can be prevented by  LORAZEPAM,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:45:19,1633616450,5/10/2015 11:45:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],in the prevention of,n/a,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:46:14,1633616589,5/10/2015 11:45:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],the prevention of,N/A,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 11:50:29,1633617674,5/10/2015 11:49:56,false,prodege,1.0,22031444,GBR,M4,Southampton,78.146.6.207,[PREVENTS],[PREVENTS],prevention,N/a,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 12:10:54,1633622048,5/10/2015 12:10:30,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],prevention,PREVENTION MEANTS IT TREATS OR STOPS,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 12:18:30,1633623593,5/10/2015 12:18:12,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS],[PREVENTS],prevention of,N/A,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 12:27:57,1633625873,5/10/2015 12:27:29,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[PREVENTS],[PREVENTS],prevention,N/A,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 12:31:23,1633626643,5/10/2015 12:30:48,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[TREATS],[TREATS],prevention of,N/A,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 12:50:42,1633631373,5/10/2015 12:50:06,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[PREVENTS],[PREVENTS],prevention of,n/a,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 12:53:53,1633632016,5/10/2015 12:52:26,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],prevention,Help,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227350,5/10/2015 13:00:44,1633633911,5/10/2015 12:59:39,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],prevention of,n/a,170,139,-1,175,148,TWrex-cause,804523-FS1,A randomized double blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and LORAZEPAM in the prevention of EMESIS due to cisplatin based chemotherapy.,EMESIS,LORAZEPAM
718227351,5/10/2015 13:55:03,1633647859,5/10/2015 13:54:40,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],in some patients,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:06:21,1633650711,5/10/2015 14:05:58,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIARRHEA CONGENITAL CHLORIDORRHEA,N/a,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:13:39,1633652665,5/10/2015 14:12:53,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],causes,n/a,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:20:24,1633654498,5/10/2015 14:19:31,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],and,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:33:45,1633657963,5/10/2015 14:33:30,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:50:20,1633662326,5/10/2015 14:48:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causes,among the causes,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:51:59,1633662706,5/10/2015 14:51:20,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],DIARRHEA,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 14:54:59,1633663638,5/10/2015 14:52:06,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],in some patients with,n/a,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 15:06:56,1633666665,5/10/2015 15:06:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DIARRHEA in some patients or CONGENITAL CHLORIDORRHEA,n/a,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 15:15:02,1633668688,5/10/2015 15:14:09,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",causes,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 15:20:53,1633670299,5/10/2015 15:19:05,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],causes are DIARRHEA with CONGENITAL CHLORIDORRHEA,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 15:20:58,1633670333,5/10/2015 15:20:24,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],causes,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 16:09:28,1633682815,5/10/2015 16:08:33,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",Among these causes are DIARRHEA in some patients with CONGENITAL CHLORIDORRHEA,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 16:13:21,1633683838,5/10/2015 16:12:33,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SIDE_EFFECT],[SIDE_EFFECT],DIARRHEA some patients CONGENITAL CHLORIDORRHEA,N/A,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227351,5/10/2015 16:14:01,1633684023,5/10/2015 16:12:59,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[SYMPTOM],[SYMPTOM],in some patients,n/a,170,221,1,177,245,TWrex-cause,812827-FS1,"Among these causes are receipt of thiazide diuretics, loss of gastric secretions (even in patients with achlorhydria), sweat losses in patients with cystic fibrosis, and DIARRHEA in some patients with villous adenomas or CONGENITAL CHLORIDORRHEA",DIARRHEA,CONGENITAL CHLORIDORRHEA
718227352,5/10/2015 13:41:00,1633644295,5/10/2015 13:40:45,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],caused,xcxc,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 13:45:59,1633645571,5/10/2015 13:45:46,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 13:46:39,1633645744,5/10/2015 13:46:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],ACTINOMYCOSIS caused by ACTINOMYCES ISRAELII.,N/a,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 13:46:47,1633645760,5/10/2015 13:46:27,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[CAUSES],[CAUSES],primarily caused,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 13:50:33,1633646768,5/10/2015 13:50:07,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 13:52:56,1633647366,5/10/2015 13:52:32,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CAUSES],[CAUSES],primarily caused,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 13:54:58,1633647855,5/10/2015 13:54:40,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:22:20,1633654950,5/10/2015 14:21:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,caused by,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:26:18,1633656152,5/10/2015 14:26:04,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],ACTINOMYCES ISRAELII.,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:26:31,1633656178,5/10/2015 14:26:17,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[LOCATION] [SYMPTOM] [NONE],"[LOCATION]
[SYMPTOM]
[NONE]",no,no,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:38:45,1633659329,5/10/2015 14:38:32,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,n/a,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:40:07,1633659737,5/10/2015 14:39:43,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:41:17,1633660071,5/10/2015 14:40:49,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[CAUSES],[CAUSES],caused by,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:50:44,1633662462,5/10/2015 14:49:58,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],primarily caused,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227352,5/10/2015 14:51:57,1633662704,5/10/2015 14:51:15,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],ACTINOMYCOSIS caused by ACTINOMYCES ISRAELII.,N/A,6,44,1,18,64,TWrex-cause,810804-FS1,Human ACTINOMYCOSIS is primarily caused by  ACTINOMYCES ISRAELII.,ACTINOMYCOSIS,ACTINOMYCES ISRAELII
718227353,5/10/2015 13:10:30,1633636555,5/10/2015 13:10:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:23:43,1633639721,5/10/2015 13:23:02,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:37:19,1633643407,5/10/2015 13:37:03,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[LOCATION],[LOCATION],ANTICOAGULANTS,sxxx,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:40:32,1633644186,5/10/2015 13:39:47,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[CAUSES],[CAUSES],Drugs with GI BLEEDING,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:41:16,1633644410,5/10/2015 13:40:32,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[SIDE_EFFECT],[SIDE_EFFECT],Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:41:21,1633644413,5/10/2015 13:40:32,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated GI BLEEDING ANTICOAGULANTS,N/a,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:42:06,1633644550,5/10/2015 13:40:41,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CAUSES],[CAUSES],Drugs associated with,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:42:30,1633644679,5/10/2015 13:41:39,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:43:48,1633644992,5/10/2015 13:43:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 13:46:59,1633645846,5/10/2015 13:45:32,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 14:10:19,1633651809,5/10/2015 14:08:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,associated with,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 14:18:28,1633654045,5/10/2015 14:17:40,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],GI BLEEDING,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 14:23:38,1633655278,5/10/2015 14:22:52,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 14:34:33,1633658193,5/10/2015 14:33:17,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[CAUSES],[CAUSES],associated with,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227353,5/10/2015 14:36:41,1633658720,5/10/2015 14:36:19,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include,N/A,22,42,1,32,74,TWrex-cause,812152-FS1,"Drugs associated with GI BLEEDING include ANTICOAGULANTS (HEPARIN WARFARIN those affecting platelet function (eg, aspirin and certain other NSAIDs, clopidogrel, SSRIs), and those affecting mucosal defenses (eg, NSAIDs.",GI BLEEDING,ANTICOAGULANTS (HEPARIN WARFARIN
718227354,5/10/2015 15:15:49,1633668854,5/10/2015 15:14:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[OTHER],[OTHER],QUESTION does adding CARVEDILOL to management of (MI),asks a question,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 15:20:22,1633670086,5/10/2015 15:19:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],management,N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 15:28:57,1633672564,5/10/2015 15:28:15,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[TREATS],[TREATS],adding,N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:18:47,1633685404,5/10/2015 16:17:33,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[PREVENTS],[PREVENTS],CARVEDILOL to the management of (MI),N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:20:12,1633685714,5/10/2015 16:19:39,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[TREATS],[TREATS],management of,n/a,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:21:40,1633686053,5/10/2015 16:21:02,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],CARVEDILOL management MI,N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:22:58,1633686404,5/10/2015 16:22:13,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],management,MI is managed by carvedilol,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:27:49,1633687576,5/10/2015 16:26:56,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],management of,N/a,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:45:06,1633692557,5/10/2015 16:44:28,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],adding CARVEDILOL to the management of,n/a,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 16:51:53,1633694641,5/10/2015 16:51:27,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],management,N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 17:24:48,1633704482,5/10/2015 17:22:53,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],reduce mortality and nonfatal MI,n/a,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 17:31:13,1633706361,5/10/2015 17:30:34,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",management of,I didn´t select none.,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 18:20:37,1633720985,5/10/2015 18:19:19,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PREVENTS],[PREVENTS],reduce,N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 18:40:06,1633727717,5/10/2015 18:39:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],management of,N/A,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227354,5/10/2015 18:59:29,1633737869,5/10/2015 18:57:28,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],PubMed ID: QUESTION patients ventricular CARVEDILOL the management mortality nonfatal,na,145,90,-1,146,100,TWrex-cause,800451-FS1,"PubMed ID: 11356434  QUESTION  In patients with left ventricular dysfunction, does adding CARVEDILOL to the management of myocardial infarction (MI) reduce mortality and nonfatal MI",MI,CARVEDILOL
718227355,5/10/2015 16:23:08,1633686432,5/10/2015 16:22:48,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",often associated with,n/a,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 16:23:41,1633686593,5/10/2015 16:23:10,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],OBESITY is associated with CARPENTER SYNDROME,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 16:25:30,1633686967,5/10/2015 16:25:02,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],OBESITY associated with CARPENTER SYNDROME,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 16:32:27,1633689063,5/10/2015 16:32:04,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/a,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 16:48:32,1633693657,5/10/2015 16:48:17,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],often associated with,n/a,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 17:00:45,1633697137,5/10/2015 17:00:18,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 17:36:57,1633707947,5/10/2015 17:36:38,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[ASSOCIATED_WITH],[ASSOCIATED_WITH],often associated with,I didn´t select none.,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 18:25:42,1633722771,5/10/2015 18:24:32,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PART_OF],[PART_OF],associated,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 18:46:34,1633730704,5/10/2015 18:46:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 19:05:33,1633739944,5/10/2015 19:05:00,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],OBESITY is often associated CARPENTER SYNDROME so lifelong plan utilized maintain healthy weight.,na,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 19:16:10,1633748878,5/10/2015 19:14:04,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",associated with,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 19:19:17,1633751147,5/10/2015 19:18:53,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 19:49:38,1633771073,5/10/2015 19:48:47,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],OBESITY is often associated with CARPENTER SYNDROME,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 20:13:01,1633779848,5/10/2015 20:12:39,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.112,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227355,5/10/2015 20:29:22,1633784677,5/10/2015 20:28:52,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is often associated with,N/A,0,33,1,6,51,TWrex-cause,812672-FS1,OBESITY is often associated with CARPENTER SYNDROME so a lifelong diet plan is often utilized to maintain a healthy weight.,OBESITY,CARPENTER SYNDROME
718227356,5/10/2015 15:18:14,1633669490,5/10/2015 15:17:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],vsLACTULOSE in treatment of ACUTE HEPATIC ENCEPHALOPATHY,n/a,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 15:22:24,1633670780,5/10/2015 15:21:49,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 15:30:36,1633673080,5/10/2015 15:29:54,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],treatment,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 16:21:07,1633685954,5/10/2015 16:20:44,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 16:21:36,1633686035,5/10/2015 16:21:19,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[TREATS],[TREATS],in the treatment of,n/a,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 16:23:36,1633686574,5/10/2015 16:23:12,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],vsLACTULOSE treatment ACUTE HEPATIC ENCEPHALOPATHY,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 16:29:35,1633688189,5/10/2015 16:29:10,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],treatment,N/a,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 16:46:50,1633693188,5/10/2015 16:46:30,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],in the treatment of,n/a,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 16:54:01,1633695229,5/10/2015 16:53:30,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],treatment,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 17:34:28,1633707268,5/10/2015 17:32:13,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[TREATS],[TREATS],in the treatment,I didn´t select none.,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 18:23:12,1633721898,5/10/2015 18:22:14,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 18:42:58,1633728758,5/10/2015 18:42:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 19:02:51,1633739145,5/10/2015 19:00:45,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],"Morgan MY, Lactitol vsLACTULOSE treatment ACUTE HEPATIC ENCEPHALOPATHY cirrhotic blind, randomized trial.",na,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 19:10:47,1633741999,5/10/2015 19:09:35,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",in the treatment of,N/A,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227356,5/10/2015 19:16:23,1633749159,5/10/2015 19:14:06,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,64,34,-1,91,43,TWrex-cause,803960-FS1,"Morgan MY, Hawley KE : Lactitol vsLACTULOSE in the treatment of ACUTE HEPATIC ENCEPHALOPATHY in cirrhotic patients: a double blind, randomized trial.",ACUTE HEPATIC ENCEPHALOPATHY,LACTULOSE
718227357,5/10/2015 13:41:51,1633644489,5/10/2015 13:41:38,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[PREVENTS],[PREVENTS],which,sdsds,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 13:46:58,1633645834,5/10/2015 13:46:34,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],originate from,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 13:47:56,1633646052,5/10/2015 13:47:26,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[CAUSES],[CAUSES],originate specific focus.,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 13:48:19,1633646157,5/10/2015 13:47:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],LOCALIZATION RELATED EPILEPSIES SEIZURES,N/a,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 13:52:50,1633647360,5/10/2015 13:51:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[IS_A],[IS_A],are those in which,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 13:55:52,1633648052,5/10/2015 13:54:11,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[SYMPTOM],[SYMPTOM],originate,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 13:57:46,1633648510,5/10/2015 13:56:33,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],are those in which SEIZURES,n/a,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:25:22,1633655857,5/10/2015 14:24:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],originate from,symptom,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:27:23,1633656377,5/10/2015 14:26:51,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],SEIZURES,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:27:21,1633656378,5/10/2015 14:27:07,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[LOCATION] [NONE],"[LOCATION]
[NONE]",no,no,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:39:46,1633659633,5/10/2015 14:39:15,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],in which SEIZURES originate,n/a,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:41:05,1633660005,5/10/2015 14:40:39,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],originate,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:43:01,1633660538,5/10/2015 14:42:18,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[IS_A],[IS_A],those in which,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:51:50,1633662675,5/10/2015 14:51:22,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[IS_A],[IS_A],are those in which SEIZURES,N/A,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227357,5/10/2015 14:53:16,1633663146,5/10/2015 14:52:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],LOCALIZATION RELATED EPILEPSIES are SEIZURES,n.a,51,0,1,58,31,TWrex-cause,812796-FS1,LOCALIZATION RELATED EPILEPSIES are those in which SEIZURES originate from a specific focus.,SEIZURES,LOCALIZATION RELATED EPILEPSIES
718227358,5/10/2015 13:54:38,1633647758,5/10/2015 13:54:14,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],first line therapy,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:05:56,1633650608,5/10/2015 14:05:41,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],BLEOMYCIN therapy HODGKIN'S DISEASE,N/a,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:12:04,1633652242,5/10/2015 14:11:32,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],first line therapy,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:12:52,1633652448,5/10/2015 14:12:27,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],therapy,n/a,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:19:29,1633654201,5/10/2015 14:19:05,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],therapy for,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:33:28,1633657909,5/10/2015 14:33:02,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:48:55,1633661916,5/10/2015 14:48:04,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy for,treats,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:51:18,1633662564,5/10/2015 14:49:50,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HODGKIN'S DISEASE,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 14:52:05,1633662766,5/10/2015 14:51:53,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],first line therapy,n/a,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 15:06:11,1633666539,5/10/2015 15:05:36,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],BLEOMYCIN first line therapy for HODGKIN'S DISEASE,n/a,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 15:14:07,1633668503,5/10/2015 15:13:40,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 15:19:04,1633669708,5/10/2015 15:17:12,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],BLEOMYCIN as first line therapy for HODGKIN'S DISEASE,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 15:20:23,1633670087,5/10/2015 15:19:32,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],first line therapy,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 16:08:32,1633682536,5/10/2015 16:08:12,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],BLEOMYCIN as first line therapy for HODGKIN'S DISEASE,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227358,5/10/2015 16:12:33,1633683624,5/10/2015 16:11:46,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],BLEOMYCIN first line therapy HODGKIN'S DISEASE,N/A,122,42,-1,138,51,TWrex-cause,803567-FS1,"127 ,   135  Often used with doxorubicin, BLEOMYCIN and dacarbazine (known as the ABVD regimen) as first line therapy for HODGKIN'S DISEASE",HODGKIN'S DISEASE,BLEOMYCIN
718227359,5/10/2015 13:51:06,1633646906,5/10/2015 13:50:47,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],attacks of,N/A,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 13:57:12,1633648420,5/10/2015 13:56:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],TRIGEMINAL NEURALGIA expected attacks PAIN,N/a,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:04:32,1633650178,5/10/2015 14:03:39,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[SYMPTOM],[SYMPTOM],expected attacks,N/A,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:05:09,1633650395,5/10/2015 14:04:17,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],expected attacks of PAIN,n/a,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:14:57,1633653002,5/10/2015 14:14:32,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:30:30,1633657067,5/10/2015 14:30:04,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",no,no,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:35:29,1633658406,5/10/2015 14:34:18,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],are possible,can happen,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:38:25,1633659269,5/10/2015 14:37:44,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],NEURALGIA,N/A,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:44:43,1633661025,5/10/2015 14:44:25,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],expected attacks of PAIN,n/a,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 14:58:54,1633664556,5/10/2015 14:58:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],TRIGEMINAL NEURALGIA attacks of PAIN,n/a,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 15:02:54,1633665508,5/10/2015 15:00:44,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],attacks of PAIN,N/A,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 15:04:57,1633666106,5/10/2015 15:04:12,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],TRIGEMINAL NEURALGIA expected attacks are possible,N/A,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 15:05:35,1633666319,5/10/2015 15:04:58,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],expected attacks,DID NOT SELECT NONE,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 15:40:03,1633675460,5/10/2015 15:39:03,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]","unpredictable, and expected attacks",n/a,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227359,5/10/2015 15:41:26,1633675798,5/10/2015 15:40:57,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[SYMPTOM],[SYMPTOM],expected attacks of PAIN are possible,n/a,76,13,1,79,33,TWrex-cause,812797-FS1,"Rationale: • TRIGEMINAL NEURALGIA is unpredictable, and expected attacks of PAIN are possible at any time.",PAIN,TRIGEMINAL NEURALGIA
718227360,5/10/2015 11:31:53,1633613493,5/10/2015 11:30:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",N/A,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 11:33:50,1633613913,5/10/2015 11:33:16,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on the basis of,n/a,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 11:41:25,1633615607,5/10/2015 11:40:30,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],basis of the,n/a,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 11:49:39,1633617471,5/10/2015 11:48:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on the basis of the TEST,n/a,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:01:27,1633620068,5/10/2015 12:00:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],study,N/A,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:07:53,1633621313,5/10/2015 12:06:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],had DIABETES,none,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:13:51,1633622540,5/10/2015 12:13:33,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],basis of the,IT IS RELATED,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:23:21,1633624801,5/10/2015 12:21:42,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,"The highlighted word in capitals bears no relation, although it does in the other fragment of the sentence.",220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:32:51,1633626940,5/10/2015 12:32:06,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"test,",N/A,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:34:31,1633627322,5/10/2015 12:34:09,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on the basis of,N/A,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:57:57,1633633197,5/10/2015 12:57:27,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],test.,Test,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 12:58:25,1633633292,5/10/2015 12:57:09,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on the basis of the FASTING SERUM GLUCOSE TEST,n/a,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 13:03:20,1633634634,5/10/2015 13:02:44,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on the basis of,n/a,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 13:05:12,1633635102,5/10/2015 13:04:07,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],on the basis of the TEST,n/a,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227360,5/10/2015 13:21:14,1633639165,5/10/2015 13:20:06,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],tolerance test tolerance test.,N/A,220,180,-1,227,206,TWrex-cause,802997-FS1,"In one study that compared the oral glucose tolerance test with the fasting serum glucose test, 254 women with PCOS took both tests; 3.2% of women had diabetes on the basis of the FASTING SERUM GLUCOSE TEST and 7.5% had DIABETES on the basis of the oral glucose tolerance test.",DIABETES,FASTING SERUM GLUCOSE TEST
718227361,5/10/2015 14:56:31,1633664039,5/10/2015 14:55:36,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],empirical treatment,n/a,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 15:10:41,1633667651,5/10/2015 15:09:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CEFTAZIDIME treatment of FEBRILE NEUTROPENIA,n/a,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 15:16:35,1633669088,5/10/2015 15:16:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 15:23:27,1633671117,5/10/2015 15:22:38,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[TREATS],[TREATS],empirical treatment,N/A,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 15:24:23,1633671336,5/10/2015 15:23:28,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],CEFTAZIDIME treatment of FEBRILE NEUTROPENIA,N/A,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:14:45,1633684240,5/10/2015 16:13:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],CEFTAZIDIME as treatment of FEBRILE NEUTROPENIA,N/A,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:16:21,1633684730,5/10/2015 16:15:54,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[NONE],[NONE],n/a,IS TREATED WITH,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:17:05,1633684959,5/10/2015 16:16:13,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF] [TREATS],"[TREATS]
[PART_OF]",CEFTAZIDIME plus amikacin empirical treatment FEBRILE NEUTROPENIA,N/A,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:19:35,1633685618,5/10/2015 16:18:44,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],treatment of,Ceftazidime is the treatment,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:23:23,1633686502,5/10/2015 16:22:53,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[PREVENTS],[PREVENTS],treatment,N/a,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:40:07,1633691125,5/10/2015 16:39:28,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],as empirical treatment,there is a relation,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 16:48:54,1633693800,5/10/2015 16:48:13,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],empirical treatment,N/A,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 17:02:42,1633697565,5/10/2015 17:02:29,false,instagc,1.0,23035364,USA,"","",73.29.106.28,[TREATS],[TREATS],treatment,no,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 17:08:16,1633699188,5/10/2015 17:07:48,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS],[TREATS],treatment of,n/a,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227361,5/10/2015 17:28:08,1633705545,5/10/2015 17:27:23,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",empirical treatment of,I didn´t select none.,149,97,-1,167,108,TWrex-cause,803965-FS1,"Ariffin H, Arasu A, Mahfuzah M et al. Single daily ceftriaxone plus amikacin versus thrice daily CEFTAZIDIME plus amikacin as empirical treatment of FEBRILE NEUTROPENIA in children with cancer.",FEBRILE NEUTROPENIA,CEFTAZIDIME
718227362,5/10/2015 13:41:27,1633644431,5/10/2015 13:41:10,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[PREVENTS],[PREVENTS],Bucuk,df,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 13:46:33,1633645701,5/10/2015 13:46:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],and,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 13:47:26,1633645923,5/10/2015 13:46:48,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[IS_A],[IS_A],based survey precipitating factors.,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 13:47:53,1633646035,5/10/2015 13:46:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],alMIGRAINE and TENSION TYPE HEADACHE factors.,N/a,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 13:51:36,1633647006,5/10/2015 13:50:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 13:54:09,1633647660,5/10/2015 13:52:58,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[IS_A],[IS_A],and,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 13:56:32,1633648225,5/10/2015 13:54:59,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS] [OTHER],"[TREATS]
[OTHER]",survey of precipitating factors.,n/a,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:24:08,1633655400,5/10/2015 14:22:21,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],alMIGRAINE and TENSION TYPE HEADACHE,similar,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:26:50,1633656285,5/10/2015 14:26:20,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],TENSION TYPE HEADACHE,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:27:06,1633656322,5/10/2015 14:26:33,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:39:14,1633659496,5/10/2015 14:38:47,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:40:38,1633659905,5/10/2015 14:40:07,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[SIDE_EFFECT],[SIDE_EFFECT],precipitating factors.,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:42:17,1633660330,5/10/2015 14:41:18,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[OTHER],[OTHER],HEADACHE,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:51:21,1633662571,5/10/2015 14:50:46,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[IS_A],[IS_A],and,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227362,5/10/2015 14:53:55,1633663331,5/10/2015 14:51:57,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],alMIGRAINE TENSION TYPE HEADACHE precipitating factors.,N/A,106,93,1,126,101,TWrex-cause,814735-FS1,"1]  Zivadinov R, Willheim K, Sepic Grahovac D, Jurjevic A, Bucuk M, Brnabic Razmilic O, et alMIGRAINE and TENSION TYPE HEADACHE in Croatia: a population based survey of precipitating factors.",TENSION TYPE HEADACHE,MIGRAINE
718227363,5/10/2015 15:17:03,1633669156,5/10/2015 15:15:54,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],DYSMENORRHEA is feature of PAIN,n/a,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 15:21:21,1633670408,5/10/2015 15:20:23,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",predominate feature symptoms,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 15:29:16,1633672656,5/10/2015 15:28:58,false,instagc,1,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],predominate feature,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:19:57,1633685684,5/10/2015 16:18:48,false,instagc,1,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],DYSMENORRHEA is a feature of PAIN,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:20:46,1633685901,5/10/2015 16:20:13,false,elite,1,32303982,GBR,H2,Lytham,80.42.186.22,[SYMPTOM],[SYMPTOM],predominate feature,n/a,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:22:39,1633686309,5/10/2015 16:21:42,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],DYSMENORRHEA predominate feature PAIN,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:24:09,1633686737,5/10/2015 16:22:58,false,neodev,1,32567155,GBR,G5,Ramsgate,88.106.247.60,[MANIFESTATION],[MANIFESTATION],predominate feature,n/a,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:28:26,1633687738,5/10/2015 16:27:50,false,prodege,1,22031444,GBR,M4,Southampton,80.44.196.2,[PART_OF],[PART_OF],feature of,N/a,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:45:43,1633692761,5/10/2015 16:45:07,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],is a predominate feature of,n/a,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 16:52:51,1633694926,5/10/2015 16:51:55,false,elite,1,30064988,GBR,"","",92.19.119.181,[SYMPTOM],[SYMPTOM],symptoms,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 17:31:35,1633706531,5/10/2015 17:31:14,false,neodev,1,31910622,USA,"","",184.48.142.206,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",is a predominate feature,I didn´t select none.,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 18:21:25,1633721243,5/10/2015 18:20:38,false,prodege,1,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],symptoms,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 18:40:47,1633727833,5/10/2015 18:40:08,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],feature of,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 19:00:11,1633738099,5/10/2015 18:59:31,false,clixsense,1,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],A] Specific contraceptives dosed continuously feature PAIN are exacerbated menses.,na,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227363,5/10/2015 19:06:57,1633740337,5/10/2015 19:04:51,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",the management,N/A,163,122,1,166,134,TWrex-cause,813808-FS1,A]  Specific recommendation: • Consider oral contraceptives dosed continuously with active pills to avoid menstruation if DYSMENORRHEA is a predominate feature of PAIN or if symptoms are exacerbated by menses.,PAIN,DYSMENORRHEA
718227364,5/10/2015 11:37:17,1633614758,5/10/2015 11:37:02,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],or,n/a,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 11:40:52,1633615564,5/10/2015 11:39:41,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 11:47:03,1633616785,5/10/2015 11:46:20,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],or history of,n/a,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 11:56:22,1633618924,5/10/2015 11:56:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],or,n/a,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 12:08:31,1633621456,5/10/2015 12:07:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],or history of,N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 12:17:35,1633623368,5/10/2015 12:16:10,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,"In the information given, HEADACHE and  MIGRAINE have no relation.",0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 12:19:14,1633623717,5/10/2015 12:18:12,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],history MIGRAINE;,HEADACHES AND MIRGRAINES RELATED,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 12:30:22,1633626331,5/10/2015 12:29:07,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 12:40:10,1633628635,5/10/2015 12:39:07,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[IS_A],[IS_A],or history,N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 12:49:10,1633630846,5/10/2015 12:48:57,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[IS_A],[IS_A],or,N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 13:04:27,1633634868,5/10/2015 13:04:00,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],history,History,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 13:05:54,1633635273,5/10/2015 13:05:34,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[IS_A],[IS_A],or history,n/a,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 13:14:05,1633637451,5/10/2015 13:12:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or history of,n/a,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 13:26:52,1633640471,5/10/2015 13:26:04,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[PART_OF],[PART_OF],or,N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227364,5/10/2015 13:26:57,1633640487,5/10/2015 13:25:52,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[SYMPTOM],[SYMPTOM],"instability, hysteria, nervous tension.",N/A,0,23,1,7,31,TWrex-cause,814187-FS1,"HEADACHE or history of MIGRAINE; extremes of age; and emotional instability, hysteria, or nervous tension.",HEADACHE,MIGRAINE
718227365,5/10/2015 11:25:37,1633612029,5/10/2015 11:24:33,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"The larva, called RAT TAILED MAGGOT E tenax may cause INTESTINAL MYIASIS in humans.",N/A,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:30:53,1633613207,5/10/2015 11:30:31,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],cause,n/a,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:35:33,1633614344,5/10/2015 11:35:02,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],RAT TAILED MAGGOT may cause INTESTINAL MYIASIS,n/a,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:44:24,1633616162,5/10/2015 11:44:03,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[LOCATION],[LOCATION],INTESTINAL,"p'
[]",59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:46:06,1633616558,5/10/2015 11:45:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],may cause,n/a,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:48:05,1633617013,5/10/2015 11:47:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],may cause,N/A,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:48:21,1633617130,5/10/2015 11:46:47,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,INTESTINAL MYIASIS can be caused by  RAT TAILED MAGGOT,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 11:51:09,1633617871,5/10/2015 11:50:51,false,prodege,1.0,22031444,GBR,M4,Southampton,78.146.6.207,[CAUSES],[CAUSES],cause,N/a,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 12:12:17,1633622272,5/10/2015 12:11:35,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],cause,CAUSES IS IN THE SENTENCE,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 12:19:13,1633623709,5/10/2015 12:18:57,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],may cause,N/A,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 12:29:05,1633626144,5/10/2015 12:28:39,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[CAUSES],[CAUSES],may cause,N/A,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 12:32:30,1633626858,5/10/2015 12:32:14,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[CAUSES],[CAUSES],may cause,N/A,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 12:52:20,1633631755,5/10/2015 12:51:52,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],may cause,n/a,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 12:55:14,1633632500,5/10/2015 12:54:43,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],cause,Causes,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227365,5/10/2015 13:01:30,1633634083,5/10/2015 13:00:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],may cause,n/a,59,18,1,76,39,TWrex-cause,811199-FS1,"The larva, called RAT TAILED MAGGOT ( E tenax ), may cause INTESTINAL MYIASIS in humans.",INTESTINAL MYIASIS,RAT TAILED MAGGOT ( E
718227366,5/10/2015 13:39:42,1633643956,5/10/2015 13:39:06,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[PREVENTS],[PREVENTS],"enzymes,",cc,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 13:44:43,1633645231,5/10/2015 13:43:55,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PMR by the prominence PAIN,N/a,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 13:44:58,1633645336,5/10/2015 13:44:28,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],prominence of,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 13:45:12,1633645397,5/10/2015 13:44:28,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[CAUSES],[CAUSES],"muscle enzymes, electromyography, biopsy PAIN",N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 13:48:46,1633646301,5/10/2015 13:48:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],by the prominence of,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 13:49:46,1633646580,5/10/2015 13:48:33,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[SYMPTOM],[SYMPTOM],differentiated by the prominence,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 13:53:57,1633647637,5/10/2015 13:52:48,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],differentiated from polymyositis,n/a,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:18:25,1633654018,5/10/2015 14:16:22,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],prominence of,pain rather than weakness,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:23:46,1633655305,5/10/2015 14:23:06,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],"muscle enzymes,",N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:25:47,1633655951,5/10/2015 14:25:17,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:37:48,1633659071,5/10/2015 14:37:25,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],prominence,n/a,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:38:53,1633659399,5/10/2015 14:38:10,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[SYMPTOM],[SYMPTOM],prominence of,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:38:58,1633659429,5/10/2015 14:38:37,false,meprizescf,1,28483210,USA,WI,Minocqua,75.143.134.247,[SYMPTOM],[SYMPTOM],prominence,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:47:52,1633661644,5/10/2015 14:46:10,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],PMR differentiated from polymyositis by the prominence of PAIN over weakness.,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227366,5/10/2015 14:48:39,1633661847,5/10/2015 14:48:05,false,prodege,1,14848125,GBR,L6,Shrewsbury,86.138.223.142,[MANIFESTATION],[MANIFESTATION],prominence of PAIN,N/A,127,0,1,130,3,TWrex-cause,814468-FS1,"PMR is differentiated from polymyositis by normal muscle enzymes, electromyography, and muscle biopsy and by the prominence of PAIN over weakness.",PAIN,PMR
718227367,5/10/2015 16:24:03,1633686707,5/10/2015 16:23:35,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[SYMPTOM],[SYMPTOM],affected by,n/a,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 16:24:46,1633686860,5/10/2015 16:24:29,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[SYMPTOM],[SYMPTOM],SKIN affected by RASH,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 16:26:48,1633687267,5/10/2015 16:26:07,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SKIN affected by RASH,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 16:36:16,1633690013,5/10/2015 16:35:52,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[LOCATION],[LOCATION],affected by the,N/a,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 16:50:02,1633694190,5/10/2015 16:49:25,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],affected by the,n/a,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 17:02:00,1633697396,5/10/2015 17:01:34,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[LOCATION],[LOCATION],affected by,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 17:37:59,1633708241,5/10/2015 17:37:44,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[ASSOCIATED_WITH],[ASSOCIATED_WITH],affected by the,I didn´t select none.,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 18:27:09,1633723312,5/10/2015 18:26:45,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],affected,NA,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 18:48:36,1633731758,5/10/2015 18:47:25,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],affected by,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 19:19:28,1633751185,5/10/2015 19:17:31,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",affected by,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 19:20:37,1633751809,5/10/2015 19:20:03,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],affected by the,n/a,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 19:52:12,1633772930,5/10/2015 19:51:07,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],SKIN affected by RASH,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 20:15:32,1633780561,5/10/2015 20:14:49,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.112,[SYMPTOM] [LOCATION],"[LOCATION]
[SYMPTOM]",affected occurs,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 20:31:48,1633785556,5/10/2015 20:30:31,false,prodege,1,32302664,USA,IL,Geneseo,173.27.241.235,[LOCATION],[LOCATION],affected by the,N/A,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227367,5/10/2015 20:44:34,1633789191,5/10/2015 20:43:39,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],affected by,n/a,4,25,-1,7,29,TWrex-cause,802765-FS1,"The SKIN affected by the RASH which occurs most often on the vulva, is often thin, shiny, and scarred.",SKIN,RASH
718227368,5/10/2015 13:40:08,1633644077,5/10/2015 13:39:49,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CLOPIDOGREL,fffg,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 13:45:18,1633645420,5/10/2015 13:44:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CLOPIDOGREL therapy MI reduce,N/a,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 13:45:20,1633645428,5/10/2015 13:45:00,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 13:45:52,1633645551,5/10/2015 13:45:13,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[PREVENTS],[PREVENTS],"reduce mortality, recurrent",N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 13:49:33,1633646550,5/10/2015 13:48:47,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],used during,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 13:50:35,1633646771,5/10/2015 13:49:47,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],other standard therapy,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 13:54:21,1633647694,5/10/2015 13:53:58,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],therapy,n/a,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:19:52,1633654347,5/10/2015 14:18:27,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],standard therapy,used to treat,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:24:51,1633655676,5/10/2015 14:23:47,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],therapy,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:26:00,1633656009,5/10/2015 14:25:48,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:38:14,1633659243,5/10/2015 14:37:49,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],used in standard therapy,n/a,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:39:26,1633659532,5/10/2015 14:38:59,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],to reduce,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:40:12,1633659767,5/10/2015 14:38:54,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[TREATS],[TREATS],used during,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:49:24,1633662068,5/10/2015 14:48:40,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],used combination to reduce,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227368,5/10/2015 14:50:20,1633662310,5/10/2015 14:47:53,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],820 used combination CLOPIDOGREL and other standard therapy,N/A,128,39,-1,129,50,TWrex-cause,804305-FS1,"820  Has been used in combination with CLOPIDOGREL and other standard therapy (e.g., thrombolytic agents, heparin) during acute MI to reduce mortality, recurrent MI recurrent ischemia, or stroke.",MI,CLOPIDOGREL
718227369,5/10/2015 13:52:44,1633647322,5/10/2015 13:52:19,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[OTHER],[OTHER],different,N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:03:13,1633649886,5/10/2015 14:02:54,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PART_OF],[PART_OF],ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL BRADYCARDIA TACHYCARDIA SYNDROME,N/a,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:08:35,1633651320,5/10/2015 14:07:09,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[SYMPTOM],[SYMPTOM],INDICATIONS encompasses,N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:09:43,1633651619,5/10/2015 14:07:43,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],node dysfunction encompasses,n/a,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:16:59,1633653562,5/10/2015 14:16:32,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:31:56,1633657513,5/10/2015 14:31:40,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:42:20,1633660337,5/10/2015 14:40:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PART_OF],[PART_OF],and the,both symptoms of,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:43:43,1633660778,5/10/2015 14:42:39,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[LOCATION],[LOCATION],TACHYCARDIA SYNDROME,N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 14:48:03,1633661687,5/10/2015 14:46:46,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 15:02:01,1633665264,5/10/2015 15:01:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],encompasses ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL BRADYCARDIA TACHYCARDIA SYNDROME,n/a,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 15:10:09,1633667525,5/10/2015 15:08:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],encompasses,DID NOT SELECT NONE,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 15:10:57,1633667748,5/10/2015 15:08:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH],[ASSOCIATED_WITH],number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 15:13:08,1633668220,5/10/2015 15:11:51,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],encompasses a number of different,N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 15:44:47,1633676731,5/10/2015 15:43:43,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[NONE],[NONE],n/a,Guidelines encompass both conditions,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227369,5/10/2015 16:05:59,1633682028,5/10/2015 16:04:43,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",N/A,122,201,1,184,233,TWrex-cause,812689-FS1,"GUIDELINES FOR SPECIFIC PACEMAKER INDICATIONS  SA Node Dysfunction  SA node dysfunction encompasses a number of different ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL block, and the BRADYCARDIA TACHYCARDIA SYNDROME",ARRHYTHMIAS INCLUDING SINUS BRADYCARDIA SINUS ARREST SINOATRIAL,BRADYCARDIA TACHYCARDIA SYNDROME
718227370,5/10/2015 15:13:34,1633668336,5/10/2015 15:12:39,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],PEDICULOSIS PUBIS caused by PHTHIRUS PUBIS,n/a,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 15:19:19,1633669749,5/10/2015 15:18:41,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 15:26:22,1633671838,5/10/2015 15:25:23,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SIDE_EFFECT],[SIDE_EFFECT],occasionally affects,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 15:31:02,1633673144,5/10/2015 15:30:19,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],PEDICULOSIS PUBIS caused by infestation with PHTHIRUS PUBIS,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:17:02,1633684956,5/10/2015 16:15:56,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CAUSES],[CAUSES],PEDICULOSIS PUBIS is caused by infestation with PHTHIRUS PUBIS,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:18:39,1633685360,5/10/2015 16:17:38,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[NONE],[NONE],n/a,IS CAUSED BY,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:20:18,1633685769,5/10/2015 16:19:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],PEDICULOSIS PUBIS caused infestation PHTHIRUS PUBIS,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:21:34,1633686024,5/10/2015 16:20:45,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[OTHER],[OTHER],caused by,PEDICULOSIS PUBIS is caused by PHTHIRUS PUBIS,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:26:08,1633687109,5/10/2015 16:25:04,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[SYMPTOM],[SYMPTOM],caused by,N/a,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:43:48,1633692176,5/10/2015 16:42:03,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[OTHER],[OTHER],is caused by infestation with,pythirus pubis causes pediculosis pubis,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 16:50:57,1633694342,5/10/2015 16:50:31,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[CAUSES],[CAUSES],caused by,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 17:22:05,1633703427,5/10/2015 17:21:19,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CAUSES],[CAUSES],caused by infestation with,n/a,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 17:29:45,1633706011,5/10/2015 17:29:13,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",which caused by infestation,I didn´t select none.,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 18:17:58,1633720216,5/10/2015 18:17:23,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],caused,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227370,5/10/2015 18:38:44,1633727266,5/10/2015 18:36:19,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,0,55,1,16,69,TWrex-cause,814505-FS1,"PEDICULOSIS PUBIS which is caused by infestation with  PHTHIRUS PUBIS  [ see Figure 6 ], tends to be limited to the pubic area but occasionally affects the axillae, eyelashes, or other hairy parts of the body.",PEDICULOSIS PUBIS,PHTHIRUS PUBIS
718227371,5/10/2015 13:40:39,1633644234,5/10/2015 13:40:14,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"adenoviruses,",fsdf,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 13:45:45,1633645543,5/10/2015 13:45:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused by,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 13:46:20,1633645641,5/10/2015 13:45:20,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],COLDS caused by RESPIRATORY SYNCYTIAL VIRUSES,N/a,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 13:46:25,1633645654,5/10/2015 13:45:53,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[CAUSES],[CAUSES],caused by,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 13:50:05,1633646646,5/10/2015 13:49:35,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],caused by,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 13:52:29,1633647272,5/10/2015 13:50:36,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CAUSES],[CAUSES],caused,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 13:54:39,1633647759,5/10/2015 13:54:22,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused,n/a,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:20:59,1633654616,5/10/2015 14:19:53,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused,caused by virus,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:26:02,1633656018,5/10/2015 14:24:53,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],COLDS,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:26:15,1633656107,5/10/2015 14:26:02,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:38:32,1633659274,5/10/2015 14:38:16,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],caused by,n/a,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:39:43,1633659623,5/10/2015 14:39:26,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:40:48,1633659928,5/10/2015 14:40:12,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[CAUSES],[CAUSES],caused by,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:49:57,1633662203,5/10/2015 14:49:26,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],caused by,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227371,5/10/2015 14:51:15,1633662556,5/10/2015 14:50:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],COLDS caused RESPIRATORY SYNCYTIAL VIRUSES,N/A,15,141,1,19,170,TWrex-cause,810425-FS1,"ETIOLOGY: Most COLDS are caused by rhinoviruses, adenoviruses, coronaviruses, coxsackieviruses, influenza viruses, parainfluenza viruses, or RESPIRATORY SYNCYTIAL VIRUSES",COLDS,RESPIRATORY SYNCYTIAL VIRUSES
718227372,5/10/2015 11:19:24,1633610690,5/10/2015 11:16:56,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"Characteristics DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",N/A,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:28:03,1633612523,5/10/2015 11:25:55,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],can be characterized,n/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:30:35,1633613089,5/10/2015 11:28:26,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[ASSOCIATED_WITH],[ASSOCIATED_WITH],can be characterized by,n/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:39:30,1633615224,5/10/2015 11:38:02,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SYMPTOM],[SYMPTOM],characterized by,none,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:41:52,1633615674,5/10/2015 11:41:15,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[CAUSES],[CAUSES],PREMATURE,rtg,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:42:36,1633615859,5/10/2015 11:40:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",can be characterized by,N/A,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:43:55,1633616119,5/10/2015 11:43:21,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],can be characterized by,n/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:48:49,1633617254,5/10/2015 11:48:08,false,prodege,1.0,22031444,GBR,M4,Southampton,78.146.6.207,[MANIFESTATION],[MANIFESTATION],characterized by,N/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 11:50:50,1633617772,5/10/2015 11:49:38,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[SYMPTOM],[SYMPTOM],characterized by,n/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 12:09:33,1633621760,5/10/2015 12:08:13,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",characterized,ITS SYMPTOMS OF IT,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 12:16:45,1633623131,5/10/2015 12:15:14,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SYMPTOM],[SYMPTOM],characterized by,N/A,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 12:25:23,1633625255,5/10/2015 12:24:39,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[MANIFESTATION],[MANIFESTATION],characterized by,N/A,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 12:29:32,1633626188,5/10/2015 12:27:49,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],characterized by,n/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 12:47:13,1633630426,5/10/2015 12:46:06,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[SYMPTOM],[SYMPTOM],characterized by,n/a,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227372,5/10/2015 12:50:25,1633631281,5/10/2015 12:49:33,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],characterized,Characterised,45,17,1,101,20,TWrex-cause,813814-FS1,"Characteristics  DKC can be characterized by CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE nails, leukoplakia of the oral mucosa, continuous lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, testicular atrophy in the male carriers, and predisposition to cancer.",CUTANEOUS PIGMENTATION PREMATURE GRAYING DYSTROPHY OF THE,DKC
718227373,5/10/2015 11:43:42,1633616077,5/10/2015 11:43:27,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],including,n/a,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 11:55:49,1633618823,5/10/2015 11:55:15,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[IS_A],[IS_A],including,n/a,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 11:56:07,1633618879,5/10/2015 11:55:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Latent Viral Infections Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.,N/A,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 12:08:57,1633621566,5/10/2015 12:08:39,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],including,n/a,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 12:20:02,1633623971,5/10/2015 12:18:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",including,N/A,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 12:27:48,1633625829,5/10/2015 12:26:46,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],including,TREATS,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 12:31:56,1633626742,5/10/2015 12:30:35,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,There is no relation shown between  LATENT VIRAL INFECTIONS and  BK VIRUS ASSOCIATED NEPHROPATHY,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 12:40:21,1633628718,5/10/2015 12:40:02,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],including,N/A,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 12:55:13,1633632504,5/10/2015 12:54:47,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[IS_A],[IS_A],including,N/A,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 13:09:59,1633636395,5/10/2015 13:09:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],Increased risk of,n/a,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 13:11:35,1633636837,5/10/2015 13:11:04,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PART_OF],[PART_OF],including,Including,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 13:22:32,1633639492,5/10/2015 13:21:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[IS_A],[IS_A],including,n/a,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 13:36:36,1633643183,5/10/2015 13:36:20,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[PREVENTS],[PREVENTS],LATENT,dfsdf,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 13:39:46,1633643967,5/10/2015 13:39:02,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[SIDE_EFFECT],[SIDE_EFFECT],Increased risk reactivation,N/A,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227373,5/10/2015 13:43:00,1633644792,5/10/2015 13:42:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[MANIFESTATION],[MANIFESTATION],reactivation of,N/A,80,114,1,102,145,TWrex-cause,810548-FS1,"476 ,   477 ,   478  Latent Viral Infections  Increased risk of reactivation of LATENT VIRAL INFECTIONS including BK VIRUS ASSOCIATED NEPHROPATHY (BKVN.",LATENT VIRAL INFECTIONS,BK VIRUS ASSOCIATED NEPHROPATHY
718227374,5/10/2015 13:50:46,1633646822,5/10/2015 13:49:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],receiving therapy,N/A,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 13:56:20,1633648191,5/10/2015 13:55:46,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],benefits DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE therapy ASPIRIN,N/a,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:03:37,1633649979,5/10/2015 14:02:42,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],benefits therapy,N/A,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:04:16,1633650110,5/10/2015 14:03:33,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],lower rates of DEATH,n/a,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:14:01,1633652758,5/10/2015 14:12:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],benefits from,N/A,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:30:02,1633657014,5/10/2015 14:29:46,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [LOCATION] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:34:17,1633658118,5/10/2015 14:32:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],receiving therapy,treat better in combination with other drug,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:37:43,1633659057,5/10/2015 14:37:04,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[MANIFESTATION],[MANIFESTATION],DEATH VASCULAR,N/A,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:44:24,1633660923,5/10/2015 14:43:54,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],coumadin therapy,n/a,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 14:58:22,1633664391,5/10/2015 14:57:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE in those receiving ASPIRIN,n/a,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 15:00:43,1633664967,5/10/2015 14:59:16,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[PREVENTS],[PREVENTS],receiving ASPIRIN,N/A,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 15:04:11,1633665889,5/10/2015 15:02:29,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA aspirin,N/A,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 15:04:56,1633666104,5/10/2015 15:03:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[PREVENTS],[PREVENTS],lower rates,DID NOT SELECT NONE,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 15:39:25,1633675278,5/10/2015 15:38:59,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[TREATS],[TREATS],receiving,n/a,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227374,5/10/2015 15:47:19,1633677372,5/10/2015 15:46:56,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],analyses showing lower rates of DEATH VASCULAR,n/a,103,260,-1,148,267,TWrex-cause,800507-FS1,The benefits from coumadin therapy were further supported by secondary analyses showing lower rates of DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE and revascularization in patients receiving coumadin or aspirin plus coumadin therapy than in those receiving ASPIRIN alone.,DEATH VASCULAR DEATH MI UNSTABLE ANGINA STROKE,ASPIRIN
718227375,5/10/2015 11:37:44,1633614842,5/10/2015 11:37:18,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],"(typical angina,",n/a,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 11:41:48,1633615652,5/10/2015 11:40:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",N/A,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 11:48:50,1633617263,5/10/2015 11:47:03,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],ATYPICAL ANGINA NONANGINAL CHEST PAIN,n/a,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 11:57:39,1633619190,5/10/2015 11:56:23,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different conditions,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 12:09:50,1633621802,5/10/2015 12:08:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",symptoms,N/A,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 12:19:06,1633623680,5/10/2015 12:17:36,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,NONANGINAL CHEST PAIN and ATYPICAL ANGINA have no relation in the information given,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 12:19:45,1633623912,5/10/2015 12:19:14,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],symptoms,SYMPTOMS,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 12:32:22,1633626829,5/10/2015 12:30:23,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,"The the two words are two similar symptoms, but it is not clear if they are associated.",77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 12:41:41,1633629032,5/10/2015 12:40:11,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[SYMPTOM],[SYMPTOM],symptoms,N/A,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 12:50:05,1633631150,5/10/2015 12:49:12,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[IS_A],[IS_A],ATYPICAL ANGINA NONANGINAL CHEST PAIN,N/A,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 13:04:55,1633635007,5/10/2015 13:04:28,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],symptoms,Symptom,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 13:06:14,1633635324,5/10/2015 13:05:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],ATYPICAL ANGINA NONANGINAL CHEST PAIN,n/a,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 13:15:11,1633637663,5/10/2015 13:14:06,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],(typical,n/a,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 13:27:57,1633640758,5/10/2015 13:26:57,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[LOCATION],[LOCATION],CHEST PAIN,N/A,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227375,5/10/2015 13:29:36,1633641154,5/10/2015 13:28:26,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",N/A,77,61,1,97,76,TWrex-cause,814590-FS1,"• How would you characterize these symptoms (typical angina, ATYPICAL ANGINA NONANGINAL CHEST PAIN",NONANGINAL CHEST PAIN,ATYPICAL ANGINA
718227376,5/10/2015 13:49:23,1633646474,5/10/2015 13:49:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 13:54:11,1633647658,5/10/2015 13:53:50,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CONTRAINDICATES],[CONTRAINDICATES],METRONIDAZOLE contraindicated used PREGNANCY,N/a,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:01:30,1633649508,5/10/2015 14:00:41,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],commonly used later,n/a,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:01:43,1633649536,5/10/2015 14:00:32,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:12:07,1633652253,5/10/2015 14:11:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],used,N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:29:23,1633656815,5/10/2015 14:28:58,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:31:26,1633657374,5/10/2015 14:30:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,not used in early pregnancy,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:34:59,1633658259,5/10/2015 14:33:39,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],nonspecific vaginitis.,N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:43:22,1633660664,5/10/2015 14:42:53,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated during the first trimester,n/a,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:55:25,1633663799,5/10/2015 14:54:52,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[OTHER],[OTHER],commonly used later in PREGNANCY,N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:56:55,1633664111,5/10/2015 14:56:11,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],METRONIDAZOLE generally in PREGNANCY,n/a,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 14:58:51,1633664543,5/10/2015 14:58:10,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[OTHER],[OTHER],METRONIDAZOLE contraindicated,N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 15:00:30,1633664913,5/10/2015 14:59:15,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],"METRONIDAZOLE used later in PREGNANCY (e.g., for nonspecific vaginitis.",N/A,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 15:02:43,1633665428,5/10/2015 15:01:45,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,DID NOT SELECT NONE,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227376,5/10/2015 15:39:02,1633675193,5/10/2015 15:37:05,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated during the first trimester,n/a,114,0,-1,122,13,TWrex-cause,803184-FS1,"METRONIDAZOLE is generally contraindicated during the first trimester of pregnancy, but is commonly used later in PREGNANCY (e.g., for nonspecific vaginitis.",PREGNANCY,METRONIDAZOLE
718227377,5/10/2015 13:54:13,1633647664,5/10/2015 13:53:55,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],acute treatment,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:05:40,1633650546,5/10/2015 14:04:58,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],GALLIUM NITRATE treatment of CANCER RELATED HYPERCALCEMIA:,N/a,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:11:30,1633652115,5/10/2015 14:10:42,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[TREATS],[TREATS],acute treatment,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:12:27,1633652376,5/10/2015 14:12:13,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:19:05,1633654163,5/10/2015 14:18:30,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[TREATS],[TREATS],for acute treatment,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:33:01,1633657779,5/10/2015 14:32:43,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[TREATS] [PREVENTS] [SYMPTOM] [NONE],"[TREATS]
[PREVENTS]
[SYMPTOM]
[NONE]",no,no,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:48:03,1633661689,5/10/2015 14:46:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,treats,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:49:47,1633662161,5/10/2015 14:48:47,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HYPERCALCEMIA:,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 14:51:52,1633662701,5/10/2015 14:51:09,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],acute treatment,n/a,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 15:05:31,1633666266,5/10/2015 15:04:57,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],GALLIUM NITRATE for treatment of CANCER RELATED HYPERCALCEMIA:,n/a,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 15:13:38,1633668377,5/10/2015 15:12:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 15:17:11,1633669180,5/10/2015 15:15:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],GALLIUM NITRATE for acute treatment CANCER RELATED HYPERCALCEMIA:,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 15:19:31,1633669789,5/10/2015 15:18:57,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],acute treatment,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 16:08:11,1633682394,5/10/2015 16:07:45,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA:,N/A,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227377,5/10/2015 16:12:58,1633683760,5/10/2015 16:11:10,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[NONE],[NONE],n/a,Needs - IS TREATED WITH,81,42,-1,108,57,TWrex-cause,800072-FS1,"Warrell RP Jr, Israel R, Frisone M et al. GALLIUM NITRATE for acute treatment of CANCER RELATED HYPERCALCEMIA: a randomized, double blind comparison to calcitonin.",CANCER RELATED HYPERCALCEMIA,GALLIUM NITRATE
718227378,5/10/2015 13:48:37,1633646233,5/10/2015 13:48:05,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 13:52:16,1633647199,5/10/2015 13:50:33,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],BELL'S PALSY cause ACUTE FACIAL NERVE PARALYSIS,N/a,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 13:56:19,1633648184,5/10/2015 13:55:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[CAUSES],[CAUSES],cause of,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 13:59:04,1633648859,5/10/2015 13:58:25,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[CAUSES],[CAUSES],common cause,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 13:59:55,1633649097,5/10/2015 13:59:38,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],cause,n/a,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:28:30,1633656622,5/10/2015 14:28:12,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[LOCATION] [CAUSES] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:29:06,1633656724,5/10/2015 14:27:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause of,causes,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:31:33,1633657396,5/10/2015 14:30:06,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[CAUSES],[CAUSES],BELL'S PALSY,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:41:48,1633660174,5/10/2015 14:41:20,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],cause of,n/a,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:43:17,1633660648,5/10/2015 14:42:42,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:53:53,1633663303,5/10/2015 14:53:21,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],most common cause,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:55:23,1633663788,5/10/2015 14:54:48,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],BELL'S PALSY cause of ACUTE FACIAL NERVE PARALYSIS,n/a,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:56:52,1633664098,5/10/2015 14:56:03,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],BELL'S PALSY is common cause ACUTE FACIAL NERVE PARALYSIS,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 14:57:19,1633664209,5/10/2015 14:55:42,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[SYMPTOM],[SYMPTOM],BELL'S PALSY common cause,N/A,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227378,5/10/2015 15:00:23,1633664881,5/10/2015 14:59:51,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],common cause,DID NOT SELECT NONE,89,48,1,116,60,TWrex-cause,813382-FS1,edit] Infranuclear lesions [edit] Bell's palsy  BELL'S PALSY is the most common cause of ACUTE FACIAL NERVE PARALYSIS,ACUTE FACIAL NERVE PARALYSIS,BELL'S PALSY
718227379,5/10/2015 11:36:28,1633614616,5/10/2015 11:36:10,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],inhaled,n/a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 11:36:56,1633614719,5/10/2015 11:35:37,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.,N/A,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 11:44:35,1633616240,5/10/2015 11:43:25,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],insulin plus BASAL INSULIN GLARGINE for TYPE 2 DIABETES:,n/a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 11:52:38,1633618209,5/10/2015 11:51:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],inhaled randomised trial.,n/a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 12:04:46,1633620720,5/10/2015 12:04:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 12:13:23,1633622471,5/10/2015 12:11:55,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,TYPE 2 DIABETES  can be treated with BASAL INSULIN GLARGINE,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 12:16:06,1633623013,5/10/2015 12:15:42,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],Prandial insulin plus,INSULIN TREATS,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 12:27:20,1633625722,5/10/2015 12:26:16,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,It is not clear if BASAL INSULIN GLARGINE is a treatment or not.,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 12:37:18,1633627867,5/10/2015 12:36:04,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[OTHER],[OTHER],trial.,N/A,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 12:41:38,1633628999,5/10/2015 12:40:48,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[OTHER],[OTHER],for,N/A,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 13:01:22,1633634042,5/10/2015 13:00:26,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PART_OF],[PART_OF],trial.,Part of a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 13:04:13,1633634795,5/10/2015 13:01:44,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",versus twice daily biaspart insulin for randomised trial.,n/a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 13:04:47,1633634970,5/10/2015 13:04:32,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],inhaled,n/a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 13:07:27,1633635736,5/10/2015 13:06:49,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],for TYPE 2 DIABETES: a randomised trial.,n/a,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227379,5/10/2015 13:28:24,1633640884,5/10/2015 13:26:53,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],versus twice daily biaspart insulin for TYPE DIABETES:,N/A,169,106,-1,183,128,TWrex-cause,800590-FS1,"Rosenstock J, Lorber DL, Gnudi L, Howard CP, Bilheimer DW, Chang PC, et al. Prandial inhaled insulin plus BASAL INSULIN GLARGINE versus twice daily biaspart insulin for TYPE 2 DIABETES: a multicentre randomised trial.",TYPE 2 DIABETES,BASAL INSULIN GLARGINE
718227380,5/10/2015 15:23:54,1633671213,5/10/2015 15:23:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],presenting as,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 16:22:29,1633686275,5/10/2015 16:22:13,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[SYMPTOM],[SYMPTOM],presenting as,n/a,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 16:22:42,1633686334,5/10/2015 16:21:47,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[SYMPTOM],[SYMPTOM],INFLAMMATORY PSEUDOTUMOR presenting as FEVER,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 16:24:33,1633686814,5/10/2015 16:24:05,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],INFLAMMATORY PSEUDOTUMOR presenting as FEVER,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 16:31:37,1633688753,5/10/2015 16:31:02,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[MANIFESTATION],[MANIFESTATION],presenting as,N/a,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 16:47:49,1633693432,5/10/2015 16:47:30,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[SYMPTOM],[SYMPTOM],presenting as,n/a,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 16:59:38,1633696797,5/10/2015 16:59:04,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[SYMPTOM],[SYMPTOM],presenting,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 17:36:13,1633707751,5/10/2015 17:35:05,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]",presenting as,I didn´t select none.,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 18:24:12,1633722270,5/10/2015 18:23:41,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],presenting,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 18:45:37,1633730067,5/10/2015 18:44:28,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],presenting as,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 19:04:01,1633739525,5/10/2015 19:03:32,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],"Fisher RG, Wright PF, Johnson INFLAMMATORY PSEUDOTUMOR presenting FEVER unknown origin.",na,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 19:13:23,1633745023,5/10/2015 19:12:08,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",presenting,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 19:18:17,1633750844,5/10/2015 19:17:34,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],presenting,n/a,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 19:47:36,1633769503,5/10/2015 19:46:30,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],INFLAMMATORY PSEUDOTUMOR presenting as FEVER,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227380,5/10/2015 20:11:52,1633779421,5/10/2015 20:10:58,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.112,[CAUSES],[CAUSES],presenting as,N/A,73,34,1,77,58,TWrex-cause,812692-FS1,"Fisher RG, Wright PF, Johnson JE: INFLAMMATORY PSEUDOTUMOR presenting as FEVER of unknown origin.",FEVER,INFLAMMATORY PSEUDOTUMOR
718227381,5/10/2015 16:23:34,1633686573,5/10/2015 16:23:10,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[TREATS],[TREATS],effects of,n/a,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 16:24:28,1633686809,5/10/2015 16:23:42,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY effects of LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 16:26:06,1633687081,5/10/2015 16:25:31,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY effects of LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 16:35:50,1633689891,5/10/2015 16:35:36,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],therapy,N/a,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 16:49:24,1633693921,5/10/2015 16:48:33,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],effects of a potent,n/a,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 17:01:31,1633697283,5/10/2015 17:00:47,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[SIDE_EFFECT],[SIDE_EFFECT],effects of,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 17:37:42,1633708144,5/10/2015 17:36:59,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[CAUSES],[CAUSES],effects of a potent,I didn´t select none.,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 18:26:45,1633723146,5/10/2015 18:25:44,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SIDE_EFFECT],[SIDE_EFFECT],effects,NA,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 18:47:24,1633731151,5/10/2015 18:46:35,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],therapy,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 19:06:17,1633740152,5/10/2015 19:05:33,false,clixsense,1.0,6574449,USA,NY,Lockport,69.204.2.158,[OTHER],[OTHER],GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY premature Leydig germinal maturation (familial testotoxicosis): effects potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy four cases.,na,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 19:17:30,1633750379,5/10/2015 19:16:11,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",effects,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 19:20:02,1633751516,5/10/2015 19:19:18,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],effects,n/a,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 19:51:06,1633772123,5/10/2015 19:49:40,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY effects of LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 20:14:45,1633780316,5/10/2015 20:13:03,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.112,[SIDE_EFFECT],[SIDE_EFFECT],effects of a,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227381,5/10/2015 20:30:30,1633785121,5/10/2015 20:29:23,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[SIDE_EFFECT],[SIDE_EFFECT],effects of a potent,N/A,0,150,-1,50,218,TWrex-cause,803342-FS1,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE acetate therapy in four cases.,GONADOTROPHIN INDEPENDENT FAMILIAL SEXUAL PRECOCITY,LUTEINIZING HORMONE RELEASING FACTOR AGONIST AND MEDROXYPROGESTERONE
718227382,5/10/2015 16:24:20,1633686752,5/10/2015 16:24:05,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[TREATS],[TREATS],comparing with placebo,n/a,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 16:27:05,1633687387,5/10/2015 16:24:47,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[TREATS],[TREATS],MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 16:27:28,1633687469,5/10/2015 16:26:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],comparing MAGNESIUM SULPHATE with PRE ECLAMPSIA,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 16:36:53,1633690217,5/10/2015 16:36:18,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[TREATS],[TREATS],comparing with placebo for,N/a,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 16:50:48,1633694317,5/10/2015 16:50:03,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],for,n/a,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 17:02:43,1633697573,5/10/2015 17:02:02,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[TREATS],[TREATS],randomised trial,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 17:38:23,1633708386,5/10/2015 17:38:01,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[TREATS],[TREATS],trial comparing,I didn´t select none.,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 18:27:57,1633723654,5/10/2015 18:27:10,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trial,NA,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 18:49:08,1633732067,5/10/2015 18:48:37,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],randomised trial,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 19:20:57,1633752014,5/10/2015 19:19:29,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",with placebo,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 19:21:20,1633752181,5/10/2015 19:20:38,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],comparing with placebo for,n/a,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 19:53:27,1633773493,5/10/2015 19:52:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 20:16:01,1633780759,5/10/2015 20:15:35,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.112,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],with placebo for,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 20:32:34,1633785743,5/10/2015 20:31:49,false,prodege,1.0,32302664,USA,IL,Geneseo,173.27.241.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with placebo for,N/A,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227382,5/10/2015 20:46:02,1633789664,5/10/2015 20:44:35,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],a randomised trial comparing,n/a,95,59,-1,107,77,TWrex-cause,804676-FS1,2007 03 01  The Magpie Trial: a randomised trial comparing MAGNESIUM SULPHATE with placebo for PRE ECLAMPSIA,PRE ECLAMPSIA,MAGNESIUM SULPHATE
718227383,5/10/2015 13:48:02,1633646071,5/10/2015 13:47:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],reported,N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 13:50:32,1633646754,5/10/2015 13:48:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SIDE_EFFECT],[SIDE_EFFECT],ANTIBIOTIC ASSOCIATED DIARRHEA may range in severity MILD DIARRHEA,N/a,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 13:55:46,1633648030,5/10/2015 13:54:27,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[IS_A],[IS_A],may range in severity,N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 13:58:23,1633648651,5/10/2015 13:56:42,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[ASSOCIATED_WITH],[ASSOCIATED_WITH],has been reported with,N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 13:59:37,1633649058,5/10/2015 13:58:28,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:27:54,1633656526,5/10/2015 14:26:06,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],may range in severity,less severe of same,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:28:11,1633656557,5/10/2015 14:27:51,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:30:05,1633657026,5/10/2015 14:28:13,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],DIARRHEA,N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:41:19,1633660074,5/10/2015 14:40:04,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],range in severity from,n/a,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:42:41,1633660405,5/10/2015 14:41:22,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[MANIFESTATION],[MANIFESTATION],has been reported,n/a,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:53:19,1633663148,5/10/2015 14:52:20,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[SYMPTOM],[SYMPTOM],range,N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:54:45,1633663594,5/10/2015 14:53:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[IS_A],[IS_A],ANTIBIOTIC ASSOCIATED including MILD DIARRHEA,n/a,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:55:41,1633663842,5/10/2015 14:54:25,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[CAUSES],[CAUSES],(CDAD; from,N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:56:02,1633663916,5/10/2015 14:53:56,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],"ANTIBIOTIC ASSOCIATED nearly all anti infectives, MILD DIARRHEA",N/A,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227383,5/10/2015 14:59:50,1633664741,5/10/2015 14:57:52,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],difficile associated,DID NOT SELECT NONE,240,64,1,252,94,TWrex-cause,814753-FS1,"difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cephalexin, and may range in severity from MILD DIARRHEA to fatal colitis.",MILD DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
718227384,5/10/2015 11:26:42,1633612208,5/10/2015 11:25:39,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],b e Specific Populations PREGNANCY Category C. b c d e Lactation CALCITRIOL may be distributed into human milk.,N/A,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 11:32:20,1633613609,5/10/2015 11:30:55,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[NONE],[NONE],distributed,may be distributed,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 11:36:28,1633614615,5/10/2015 11:35:34,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],PREGNANCY Lactation CALCITRIOL may be distributed,n/a,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 11:47:37,1633616917,5/10/2015 11:46:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Category,n/a,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 11:50:06,1633617575,5/10/2015 11:48:21,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,PREGNANCY may cause  CALCITRIOL distribution into human milk,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 11:58:00,1633619259,5/10/2015 11:57:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,The sentence is too incoherent.,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 12:12:37,1633622326,5/10/2015 12:12:18,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION],[MANIFESTATION],distributed,LOOKS LIKE A MANIFCATION,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 12:20:24,1633624044,5/10/2015 12:19:14,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,It is not  clear if there is a relationship and of which type.,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 12:30:31,1633626407,5/10/2015 12:29:05,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[OTHER],[OTHER],may be distributed into milk.,N/A,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 12:33:04,1633627004,5/10/2015 12:32:32,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[NONE],[NONE],N/A,The text is non-sensical,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 12:54:10,1633632178,5/10/2015 12:52:22,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[OTHER],[OTHER],distributed into human milk.,n/a,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 12:55:59,1633632680,5/10/2015 12:55:15,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may,May be produced,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 13:01:44,1633634168,5/10/2015 13:01:07,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Specific Populations,n/a,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 13:01:57,1633634242,5/10/2015 13:01:31,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],may be distributed,n/a,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227384,5/10/2015 13:16:53,1633638037,5/10/2015 13:15:11,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[OTHER],[OTHER],PREGNANCY CALCITRIOL,N/A,32,88,-1,40,98,TWrex-cause,803225-FS1,"b ,    e  Specific Populations  PREGNANCY  Category C.  b ,   c ,   d ,   e  Lactation  CALCITRIOL may be distributed into human milk.",PREGNANCY,CALCITRIOL
718227385,5/10/2015 11:39:59,1633615317,5/10/2015 11:38:56,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused by,n/a,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 11:47:09,1633616788,5/10/2015 11:45:38,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[ASSOCIATED_WITH]",A DISEASE caused by RICKETTSIA TYPHI and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,N/A,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 11:52:16,1633618104,5/10/2015 11:50:46,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[CAUSES],[CAUSES],caused by,n/a,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 12:03:34,1633620470,5/10/2015 12:03:12,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 12:13:47,1633622521,5/10/2015 12:13:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 12:22:47,1633624620,5/10/2015 12:22:10,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused by,CAUSED BY IS IN THE SENTENCE,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 12:23:49,1633624895,5/10/2015 12:22:38,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[OTHER],[OTHER],caused by,DISEASE is caused by RICKETTSIA TYPHI,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 12:35:38,1633627522,5/10/2015 12:34:58,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],caused by,N/A,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 12:52:09,1633631725,5/10/2015 12:51:10,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[NONE],[NONE],N/A,disease caused by,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 13:07:48,1633635800,5/10/2015 13:07:23,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],caused,Caused,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 13:07:49,1633635802,5/10/2015 13:07:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[IS_A],[IS_A],caused by,n/a,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 13:17:48,1633638244,5/10/2015 13:17:28,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 13:32:55,1633642254,5/10/2015 13:32:27,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[CAUSES],[CAUSES],DISEASE caused by RICKETTSIA TYPHI,N/A,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 13:33:11,1633642296,5/10/2015 13:32:57,false,superrewards,1.0,32459436,USA,VA,Manassas,207.244.77.3,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],and,fgfdg,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227385,5/10/2015 13:33:29,1633642391,5/10/2015 13:32:09,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[MANIFESTATION],[MANIFESTATION],infection rats,N/A,2,21,1,8,37,TWrex-cause,810798-FS1,A DISEASE caused by  RICKETTSIA TYPHI  and occurring in nature as a mild infection of rats and transmitted from rat to rat by the rat louse or flea.,DISEASE,RICKETTSIA TYPHI
718227386,5/10/2015 13:49:06,1633646395,5/10/2015 13:48:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[OTHER],[OTHER],pre,N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 13:53:49,1633647600,5/10/2015 13:52:17,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",symptoms of HYPOGLYCEMIA monitoring GLUCOSE at home,N/a,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:00:31,1633649236,5/10/2015 13:59:06,false,clixsense,1.0,29155723,GBR,H8,Liverpool,92.15.162.187,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],frequent monitoring,N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:00:40,1633649286,5/10/2015 13:59:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SYMPTOM],[SYMPTOM],symptoms,n/a,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:11:31,1633652116,5/10/2015 14:10:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,67.183.5.219,[SYMPTOM],[SYMPTOM],symptoms of,N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:28:57,1633656704,5/10/2015 14:28:31,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.125,[CAUSES] [PREVENTS] [LOCATION] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:30:43,1633657106,5/10/2015 14:29:06,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],urge more frequent monitoring,monitor to check,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:33:34,1633657939,5/10/2015 14:31:34,false,clixsense,1.0,17950689,GBR,Y9,Porth,217.43.32.119,[SYMPTOM],[SYMPTOM],HYPOGLYCEMIA,N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:42:52,1633660472,5/10/2015 14:41:50,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],reduce perioperative risk: frequent monitoring of GLUCOSE,n/a,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:43:55,1633660843,5/10/2015 14:43:18,false,meprizescf,1.0,28483210,USA,WI,Minocqua,75.143.134.247,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],monitoring,n/a,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:54:51,1633663601,5/10/2015 14:53:54,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[PREVENTS],[PREVENTS],(fasting and pre meal),N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:56:07,1633663943,5/10/2015 14:55:24,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HYPOGLYCEMIA monitoring of GLUCOSE,n/a,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:58:08,1633664353,5/10/2015 14:57:20,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[PART_OF],[PART_OF],HYPOGLYCEMIA monitoring GLUCOSE,N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 14:59:14,1633664600,5/10/2015 14:56:52,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[ASSOCIATED_WITH] [PART_OF] [IS_A],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",HYPOGLYCEMIA frequent monitoring GLUCOSE,N/A,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227386,5/10/2015 15:01:44,1633665215,5/10/2015 15:00:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]",perioperative risk:,DID NOT SELECT NONE,120,191,-1,131,198,TWrex-cause,804838-FS1,"Intervention to reduce perioperative risk: Non drug intervention: Educate Mr. DM on his perioperative risk, symptoms of HYPOGLYCEMIA and cardiac ischemia and urge more frequent monitoring of GLUCOSE at home (fasting and pre meal) and smoking cessation.",HYPOGLYCEMIA,GLUCOSE
718227387,5/10/2015 11:42:47,1633615894,5/10/2015 11:41:27,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in,n/a,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 11:53:04,1633618271,5/10/2015 11:52:09,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],"Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",N/A,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 11:54:50,1633618583,5/10/2015 11:54:14,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[TREATS],[TREATS],in,n/a,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 12:08:03,1633621347,5/10/2015 12:07:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in,n/a,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 12:18:00,1633623420,5/10/2015 12:17:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],in,N/A,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 12:26:33,1633625495,5/10/2015 12:26:08,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],in,TREATS,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 12:29:21,1633626168,5/10/2015 12:28:08,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,RENAL CELL CARCINOMA can be treated with  INTERLEUKIN 2 PLUS INTERFERON ALPHA,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 12:39:41,1633628529,5/10/2015 12:38:00,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[NONE],[NONE],N/A,It is not clear what relation in any.,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 12:54:16,1633632203,5/10/2015 12:54:03,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[SYMPTOM],[SYMPTOM],in,N/A,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 13:09:27,1633636274,5/10/2015 13:08:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in,n/a,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 13:10:22,1633636503,5/10/2015 13:09:49,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[NONE],[NONE],N/A,No relation,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 13:21:14,1633639166,5/10/2015 13:20:37,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],in,n/a,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 13:35:50,1633642985,5/10/2015 13:35:33,false,superrewards,1.0,32459436,USA,DE,"",108.59.8.210,[CAUSES],[CAUSES],interferon,dfdv,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 13:38:16,1633643598,5/10/2015 13:37:30,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[SYMPTOM],[SYMPTOM],INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA,N/A,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227387,5/10/2015 13:38:29,1633643672,5/10/2015 13:37:18,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[SYMPTOM],[SYMPTOM],INTERFERON ALPHA RENAL,N/A,118,79,-1,137,114,TWrex-cause,800082-FS1,"Boccardo F, Rubagotti A, Canobbio L et al. Interleukin 2, interferon alpha and INTERLEUKIN 2 PLUS INTERFERON ALPHA in RENAL CELL CARCINOMA",RENAL CELL CARCINOMA,INTERLEUKIN 2 PLUS INTERFERON ALPHA
718227388,5/10/2015 11:37:01,1633614727,5/10/2015 11:36:44,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],OF,n/a,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 11:39:40,1633615256,5/10/2015 11:39:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 11:46:19,1633616611,5/10/2015 11:45:39,false,clixsense,1.0,24329110,USA,FL,Tampa,66.192.17.130,[PART_OF],[PART_OF],from,n/a,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 11:56:02,1633618865,5/10/2015 11:55:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ANALYSIS OF in human biopsy material,n/a,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 12:07:33,1633621222,5/10/2015 12:05:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[DIAGNOSE_BY_TEST_OR_DRUG] [OTHER],"[DIAGNOSE_BY_TEST_OR_DRUG]
[OTHER]",material from,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 12:16:09,1633623014,5/10/2015 12:14:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],reactional cases.,none,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 12:18:10,1633623495,5/10/2015 12:16:51,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],biopsy material from,RELATED,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 12:29:05,1633626143,5/10/2015 12:28:25,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],material from,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 12:39:05,1633628393,5/10/2015 12:38:06,false,prodege,1.0,27934334,GBR,C7,Coventry,109.150.225.5,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ANALYSIS,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 12:48:56,1633630774,5/10/2015 12:48:30,false,instagc,1.0,31214995,AUS,02,Cardiff,60.241.159.249,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],from,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 13:03:59,1633634744,5/10/2015 13:02:08,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],cases.,Cases,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 13:05:33,1633635213,5/10/2015 13:05:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],human biopsy material,n/a,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 13:12:31,1633637104,5/10/2015 13:12:12,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],from,n/a,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 13:25:51,1633640281,5/10/2015 13:24:30,false,clixsense,1.0,6362702,GBR,B7,Bristol,90.222.102.171,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reactional cases.,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227388,5/10/2015 13:26:02,1633640327,5/10/2015 13:24:37,false,coinworker,1.0,20231698,USA,"","",172.56.32.19,[OTHER],[OTHER],ANALYSIS,N/A,103,23,1,109,72,TWrex-cause,811651-FS1,Quantitative real time PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA in human biopsy material from LEPROSY and reactional cases.,LEPROSY,PCR ANALYSIS OF MYCOBACTERIUM LEPRAE DNA AND MRNA
718227389,5/10/2015 15:14:34,1633668530,5/10/2015 15:13:45,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],LISTERIA INFECTIONS caused by L MONOCYTOGENES,n/a,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 15:19:43,1633669845,5/10/2015 15:19:19,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 15:28:14,1633672370,5/10/2015 15:26:23,false,instagc,1.0,13864884,USA,AZ,Phoenix,184.98.62.56,[TREATS],[TREATS],Treatment,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 15:31:55,1633673319,5/10/2015 15:31:03,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],LISTERIA INFECTIONS caused by L MONOCYTOGENES,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:17:33,1633685131,5/10/2015 16:17:04,false,instagc,1.0,20312760,GBR,I2,Manchester,90.244.159.123,[CAUSES],[CAUSES],LISTERIA INFECTIONS caused by L MONOCYTOGENES,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:19:39,1633685639,5/10/2015 16:18:40,false,elite,1.0,32303982,GBR,H2,Lytham,80.42.186.22,[CAUSES],[CAUSES],caused by,n/a,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:21:01,1633685941,5/10/2015 16:20:19,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],LISTERIA INFECTIONS caused by L MONOCYTOGENES,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:22:13,1633686201,5/10/2015 16:21:35,false,neodev,1.0,32567155,GBR,G5,Ramsgate,88.106.247.60,[NONE],[NONE],n/a,The sentence doesn't make sense,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:26:55,1633687302,5/10/2015 16:26:10,false,prodege,1.0,22031444,GBR,M4,Southampton,80.44.196.2,[ASSOCIATED_WITH],[ASSOCIATED_WITH],caused by,N/a,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:44:27,1633692387,5/10/2015 16:43:49,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],infections caused by,n/a,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 16:51:24,1633694503,5/10/2015 16:50:59,false,elite,1.0,30064988,GBR,"","",92.19.119.181,[CAUSES],[CAUSES],caused by,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 17:22:52,1633703756,5/10/2015 17:22:05,false,clixsense,1.0,26847653,NLD,03,Warnsveld,213.93.50.164,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment of infections caused by,n/a,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 17:30:33,1633706179,5/10/2015 17:29:48,false,neodev,1.0,31910622,USA,"","",184.48.142.206,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Treatment of infections caused,I didn´t select none.,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 18:19:18,1633720642,5/10/2015 18:17:59,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],caused,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
718227389,5/10/2015 18:39:14,1633727423,5/10/2015 18:38:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,0,56,1,18,71,TWrex-cause,811897-FS1,"LISTERIA INFECTIONS  Treatment of infections caused by  L MONOCYTOGENES  (e.g., infections during pregnancy, granulomatosis infantiseptica, sepsis, meningitis, endocarditis, foodborne infections.",LISTERIA INFECTIONS,L MONOCYTOGENES
